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ABSTRACT OF DISSERTATION
BODY WEIGHT AND MORTALITY AMONG ADULTS WHO NEVER SMOKED
by
Pramil N. Singh
Doctor of Public Health in Epidemiology
Loma Linda University, Loma Linda California, 1999
Kristian D. Lindsted, Chair

Most prospective studies identify an increased mortality risk for adults of high
body mass index (> 27 kg/m2) that is commonly attributed to the effects of excess body
fat, and also identify an increased mortality risk for adults of low body mass index (< 21
kg/m2), an association that, if causal among healthy adults, is without adequate
pathophysiologic support.
In this dissertation, I have conducted three studies that continue the investigation
of adiposity in relation to mortality among never-smoking adults of the California
Seventh-day Adventist population. Among never-smoking adults of the Adventist
Mortality Study (1960-1985), the relation between body mass index (BMI) and all-cause
mortality has been examined and the investigators found a direct positive relation among
middle-aged men, older men, and middle-aged women, and a J-shaped relation among
older women.
In the first study, I found that among 12,576 never-smoking women of the
Adventist Mortality Study, the risk due to high BMI (> 27 kg/m2) was primarily due to
cardiovascular disease and the risk due to low BMI (< 21 kg/m2) among older women
was primarily due to cardiovascular and respiratory diseases. In the second study, I
examined the relation between BMI and mortality among 20,346 never-smoking adults of
iii

the Adventist Health Study (1976-1988) and found a direct positive relation among
middle-aged men, older men, middle-aged women, and a J-shaped relation among older
women. Further study of the older women indicated that increased risk due to the lowest
BMI (13.4-20.6 kg/m2) was only evident among those who had not used hormone
replacement therapy, and that this risk was primarily due to cardiovascular and
respiratory disease. In the third study, I related weight gain over a 17-year interval to all
cause mortality among 6,030 never-smoking members of the 1960 and 1976 cohorts and
found evidence implicating weight gain (> 10 kg) as a risk factor and that this risk
remained evident for weight gains recorded at the sixth, seventh, and eighth decade.
The findings from these studies implicate obesity as a risk factor throughout
adulthood and raise the possibility that lean older women can experience an increased
mortality risk that may be due to their lower levels of adipose tissue-derived estrogens.
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CHAPTER 1
INTRODUCTION

A relation between body weight and mortality among adults has been documented
in numerous prospective cohort studies in which a baseline measure of Quetelefs body
mass index (weight in kilograms divided by the square of height in meters) is related to
the subsequent risk of death. Quetelet’s body mass index (BMI) can be interpreted as
body weight corrected for height and is commonly regarded as a surrogate measure of
adiposity (1-2). This index has widespread use in public health and forms the basis for
the current United States weight guidelines that include a recommended BMI range of 19
to 25 kg/m2 for healthy adults (3-5). For a man of average height (5’ 10”) this
recommendation corresponds to a range of body weight of 132 to 174 pounds. For a
woman of average height (5’ 5”) this recommendation corresponds to a range of body
weight of 114 to 150 pounds.
Most prospective cohort studies identify an increased mortality risk for adults of
high BMI (usually above 27 kg/m2) that is commonly attributed to the effects of excess
body fat (6-8), and also identify an increased mortality risk for adults of low BMI
(usually below 21 kg/m2), an association that, if causal among healthy adults, is without
adequate pathophysiologic support. The increased mortality risk among adults of low
BMI in previous studies has been attributed to inadequate methodologies that did not
account for the effects of cigarette smoking (9), disease-related weight loss (9-11),
alcohol use (12-13), and poverty (10,14-15) when estimating the independent association
between body weight and mortality.
Members of the Seventh-day Adventist Church are characterized by a strict
adherence to church proscriptions on tobacco and alcohol use, and a large proportion of
the membership follow a church recommended vegetarian diet pattern (16). The relation
1

between lifestyle factors and mortality among Seventh-day Adventist adults residing in
the state of California has been examined in two prospective cohort investigations known
as the Adventist Mortality Study [1960-1985] (17-18) and the Adventist Health Study
[1976-1988] (16,19). Baseline data from these cohorts indicate a very low prevalence of
current cigarette smoking and alcohol use, and low intake levels of saturated fat. The low
prevalence of many of the traditional risk factors for chronic disease (cigarette smoking,
alcohol use, saturated fat intake) among these cohort members who still exhibit a wide
range of body weights, provides a unique opportunity to study the independent relation
between body weight and mortality among apparently healthy adults.
To date, the relation between BMI and all-cause mortality has been reported
among never-smoking 30-74 year-old men (20) and women (21) of the Adventist
Mortality Study, and among men, BMI has also been related to risk of specific fatal
diseases (cardiovascular, cancer, respiratory) (21). The Adventist Mortality Study
findings indicate a direct positive relation between BMI and all-cause mortality among
middle-aged (age 30-54 years) men, older men (age 55-74 years), and middle-aged
women, and a J-shaped relation among older women. A causal interpretation of these
findings could be that low body weight is not a risk factor among men and middle-aged
women, but can be a risk factor among older women.
In this dissertation, I have conducted three new studies of body weight and
mortality among cohort members of the Adventist Mortality Study (AMS) and Adventist
Health Study (AHS).

In the first study (entitled “Body Weight and 26-Year Risk of

Mortality from Specific Diseases among Women Who Never Smoked”), I have examined
the relation between BMI and risk of specific fatal diseases among the 12,576 neversmoking AMS women (aged 30-74 years) in order to evaluate whether the all-cause
mortality trends observed in this cohort (21) are consistent with plausible
pathophysiologic mechanisms by which high and low body weight can increase risk of
2

specific fatal diseases among women. In the second study (entitled “Body Weight and
Mortality Among Adults Who Never Smoked”), I have examined the relation between
BMI and mortality (all-cause, disease-specific) among 20,346 never-smoking AHS
cohort members (aged 25-84 years) and then compare these findings to the AMS
findings. In the third study (entitled “Age, Weight Gain, and Mortality among Adults
Who Never Smoked”), I have examined the relation between weight gain (over a 17-year
interval) and mortality among the 6,030 never-smoking adults who were members of both
the AMS (body weight given in 1960) and AHS (body weight given in 1976) cohorts.
Since the three studies that comprise this dissertation are presented as separate formatted
manuscripts, I have provided a closing chapter (Chapter 6) to summarize the findings and
provide conclusions based on the accumulated data from the AMS and AHS cohorts.
The three studies of this dissertation will evaluate the following hypotheses
(alternate hypothesis format): 1) That there is a direct relation between BMI and all
cause mortality among men 2) That there is a direct relation between BMI and all-cause
mortality among middle-aged women (third, fourth, fifth decade) 3) That there is a J - or
U - shaped relation between BMI and mortality among older women (at or above the
sixth decade) that is dependent on other co-morbid factors 4) That large weight gain (>
20 kg) over a 17 year interval is a risk factor through the eighth decade.

3

CHAPTER 2
REVIEW OF THE LITERATURE ON BODY WEIGHT AND MORTALITY AMONG
ADULTS

I conducted a detailed search of the online databases of the National Library of
Medicine and found that from 1959 to 1998, measures of adiposity such as body mass
index (BMI) and relative weight (relative to height-specific Metropolitan Life Insurance
Tables) have been related to subsequent risk of death in 86 prospective studies (10-14,20100). The majority of these studies report a J- or U- shaped relation between adiposity
and mortality in the total study population. In this chapter, I have reviewed and critiqued
the methodologies for control of confounding that have been used in these studies, and
then have provided a set of recommendations for the control of confounding. Based on
these recommendations, I have then selected studies in which adequate control of
confounding has been accomplished, and have reviewed the findings from these studies.

A Review of the Methodologies for the Control of Confounding in Prospective Studies of
Body Weight in relation to Mortality

Confounding by Cigarette Smoking and Disease-related Weight Loss

In a 1987 review of 25 prospective studies relating measures of adiposity to
mortality risk, Manson et al (9) proposed that 1) the apparent increase in mortality risk
among adults of low body weight may be due to the increased prevalence of cigarette
smoking or disease-related weight loss among those of low body weight, and 2) the
apparent null findings for obesity estimated from multivariate methods may represent an
attenuation of the true risk if the known effects of obesity - glucose intolerance,
4

hypertension, hyperlipidemia - had been controlled for in a multivariate analysis.
Manson et al, then evaluated each of the 25 studies based on these criteria - control for
smoking, exclusion of the early mortality to eliminate those subjects who were lean due
to disease, appropriate absence of multivariate adjustment for the effects of obesity - and
found that none of the studies met all three criteria. It was noted in the review, however,
that where at least some of the criteria were met, the weight-mortality relation tended to
be “direct” (positive) or “J-shaped, nadir < average”. Manson et al concluded that the
increased mortality risk among lean subjects that produced the J or U-shaped trend may
represent confounding by cigarette smoking and disease-related weight loss.
The review by Manson et al had a profound impact on the study of body weight
and mortality. Since 1987, many investigators who have evaluated the BMI-Mortality
relation in a prospective study have cited this review in support of their analytic method
that involved a control for the possible confounding effects of smoking and diseaserelated weight loss.

Confounding by Cigarette Smoking

An increased prevalence (> 50%) of cigarette smoking among lean subjects has
been documented in a number of populations (101), with one study of British men (64)
indicating a 93% prevalence of smoking among very lean men (< 17 kg/m2). This
association between low body weight and cigarette smoking has been attributed to the
increased energy expenditure, increased metabolic rate, and changes in energy storage
that occurs among cigarette smokers (102-104).

These data taken together with the

accumulated evidence of a strong association between smoking and fatal disease (105),
implicate smoking as a possible confounder of the relation between low body weight and
mortality.
5

Methods for control of confounding by cigarette smoking. In most prospective
studies that have examined the body weight-mortality relation with a control for the
effects of cigarette smoking, the method of control usually involves either multivariate
adjustment or exclusion of smokers from the analysis. Of the two methods, multivariate
adjustment is probably less effective.
When data on smoking history is limited to simple dichotomous classifications of
current smoking (yes/no) and former smoking (yes/no), multivariate adjustment for these
indicators can still allow residual confounding by duration and intensity of the smoking
habit. When data on smoking history allows for an estimation of the duration and
intensity (i.e. pack-years), then the extent to which the estimation method does not
measure true behavior represents the extent to which residual confounding by duration
and intensity remains after the multivariate adjustment.
In contrast to multivariate adjustment, exclusion of current and former cigarette
smokers from the analysis can eliminate the possibility of residual confounding by
duration and intensity since the unmeasured effects of a smoking habit could not
confound the body weight-mortality relation among “true” never-smokers. Exclusion of
smokers does not, however, prevent bias due to misclassification of smoking status.
Misclassification of self-reported smoking status has been evaluated in a number of
populations (106), and misclassification rates tend to be low (3-5% among ever-smokers,
1.3% in a large sample of never-smoking women).
Therefore, in the study of a large free-living population, exclusion of smokers
represents a practical and effective method to control for confounding of the body weightmortality relation by cigarette smoking. Some investigators choose to exclude only
current smokers and either control for past smoking by multivariate adjustment or ignore
past smoking on the assumption that it is not a strong confounder.

Although data on the

extent to which past smoking may specifically confound the BMI-mortality is limited,
6

there is data from two large cohorts of men (39) and women (45) that indicate an
increased mortality risk for lean former smokers that does not exist among lean neversmokers. It could be hypothesized that former-smokers may represent subjects who have
quit smoking due to a diagnosed illness (sometimes referred to as the “sick quitter”
effect) (107) or may represent a group that is more likely to initiate a smoking habit
during the follow-up due to relapse. Thus, if sufficient sample size remains, exclusion of
current and former-smokers from the analysis seems a conservative, albeit justified,
analytic method.
Evidence for the confounding effect of cigarette smoking on the relation between
BMI and Mortality.

In Table 2.1,1 present data from 13 prospective investigations in

which BMI or relative weight (RW) has been related to mortality' risk in smoking statusspecific analyses where a risk ratio for weight categories was given in a published report
or could be calculated from data presented in a published report. In 12 out of 13 of these
investigations, the risk of death for the lowest body weight category relative to a middle
category was lower among never-smokers or non-smokers (never + former) as compared
to either the total population, current smokers, or former smokers. x\dditionally, I found
three studies [Charleston Heart Study (52), Lipid Research Clinics Program (62), Sempos
re-analysis of Framingham Heart Study (108)] in which the body weight-mortality
relation was evaluated in smoking status specific analyses that involved fitting linear and
quadratic functions to the body weight-mortality relation. In two (52,62) out of three of
these studies, the mortality minimum for non-smokers was at a lower body weight than
for smokers or the total population.
Thus, the accumulated data indicates that increased mortality risk among lean
adults can be partly attributable to the effects of cigarette smoking among those adults
who are lean due to cigarette smoking. I therefore conclude that evaluation of the body
weight-mortality relation in a smoking status-specific analysis gives the most insight into
7

the effect of body weight on mortality among healthy adults.

Confounding by Disease-related Weight Loss

The enrollment for a large prospective study of free-living adults will include a
subset who have lost body weight due to a clinical or sub-clinical disease that is present
at baseline and will ultimately contribute to their death during the follow-up. If the
purpose of the prospective study is to evaluate the role of baseline body weight in the
etiology of fatal disease among healthy subjects, then this subset who are lean at baseline
due to disease will confound the estimates of risk due to low body weight by artificially
increasing the mortality rate observed among those subjects with low body weight.
Methods for control of confounding by disease-related weight loss. One method to
control for this confounding would be to use data collected at baseline to exclude from
the analysis the subset of the study population who are lean due to disease. When
attempting to identify subjects who have experienced disease-related weight loss at
baseline, it is important to note that this disease may be diagnosed or undiagnosed at
baseline. Therefore, in the case of diagnosed disease, exclusions can only be made if the
baseline data collection (i.e. survey, interview, medical records) involves a complete
recording of disease history. In the case of symptomatic undiagnosed disease, exclusions
might be possible if the baseline data collection includes an accurate report of pertinent
symptoms, physical complaints, and/or recent weight loss. In the case of asymptomatic
undiagnosed disease, often referred to as “occult disease”, the only presumptive indicator
of the subsequent pathology might be recent weight loss. These exclusion criteria are
summarized in Table 2.2 .
A second method of controlling for this confounding is based on the premise that
subjects who are experiencing disease-related weight loss at baseline will have shorter
8

survival times than subjects who are not experiencing disease-related weight loss.
Therefore, one method of excluding subjects who are lean due to disease, would be to
exclude those subjects who die during the first n years of follow-up, where « is a period
of time from baseline that is designated by the investigator. For the purpose of this
dissertation, I will refer to this method as the “early mortality exclusion”, and n as the
duration of the early mortality that was excluded.
Among the studies that have used the early mortality exclusion, n has ranged from
1 to 17 years. What value of n is optimal? The answer to this question remains
controversial. Some investigators have cited the principle of “intention to treat” in which
as many subjects as is possible should be retained in the analysis, and therefore argued for
excluding no more than 4 years of follow-up (25). Lee and Manson have argued in a
recent editorial that the effects of antecedent disease can persist up to 17 years (109), an
effect that, if confirmed, suggests that the first 17 years of follow-up should be excluded.
Finally, Allison et al (110) have used simulated prospective data to argue for no apparent
effect of early mortality exclusions with an n that exceeds 20 years.
I propose that it is inappropriate to apply a single value of n to the early mortality
exclusion of all cohorts. Since the prevalence of baseline disease will vary between
cohorts, so will the confounding effect of disease-related weight loss. In healthier cohorts
the duration of time required for disease to become manifest will be longer, and therefore
the duration of early follow-up that must be excluded should be longer. For example,
among Adventist Health Study cohort members, a “low-risk” subgroup of the US
population, Lindsted et al have provided evidence for a “healthy volunteer effect” that
attenuates mortality rates up to six years after baseline (111). These data suggest that in
the Adventist Health Study cohort, six or more years of follow-up would have to be
excluded in order to remove bias from occult disease.

9

If it is in fact inappropriate to apply a single n for the early mortality exclusion to
all prospective studies, then how should n be determined? It follows that if the increased
risk due to low body weight reflects disease-related weight loss among subjects who will
die from the disease shortly after baseline, then the risk due to low body weight should be
especially pronounced shortly after baseline. This latter indicates by definition a time
dependency in the hazard due to low body weight. Therefore, traditional methods for
evaluating time dependency (plots of the hazard versus time, time-dependent covariates)
can be used to identify changes in the risk due to low body weight from early follow-up
to later follow-up, and hence the duration of the early follow-up to be excluded can be
determined empirically.
An example of this analytic method using data from a population of neversmoking men (20) is given in the Appendix (“Findings from Men of the Adventist
Mortality Study”). Among these men, the risk due to low BMI (14.3 to 22.5 kg/m2) of
body weight is increased relative to the middle range of BMI (22.6 to 27.4 kg/m2) during
the first 14 years of follow-up, but “crosses over” into being protective relative to the
middle range during 15-26 years of follow-up (Appendix, “Findings from Men of the
Adventist Mortality Study”, Figures 1-2). If the increased risk due to low BMI during the
first 14 years is assumed to be attributable to confounding by disease-related weight loss,
then this confounding is controlled in the analysis of men surviving 15 to 26 years after
baseline (Appendix, “Findings from Men of the Adventist Mortality Study”, Table 2).
Evidence for the confounding effect of disease-related weight loss on the relation
between BMI and Mortality. In table 2.3,1 present the published data from 8 prospective
studies that evaluated the relation between body weight and mortality in analyses that
examine the effect of some or all of the exclusion criteria given in table 2.2 on the risk
due to low body weight. These data indicate that exclusion of subjects based on criteria
given table 2.2 resulted in an attenuation of the risk due to low body weight in 6 out of 8
10

of the studies.
In addition, among older women (age 65-74 years) of the National Health and
Nutrition Survey I (NHANES I) cohort, Rumpel (10) reported hazard ratios for categories
of BMI by weight loss (> 8.55% of initial body weight, < 8.55% of initial body weight)
and found a 130% increase in risk for low BMI + weight loss relative to low BMI + no
weight loss. These NHANES I data taken together with data from 8 studies in table 2.3,
therefore indicate that in 7 out of 9 studies the risk due to the lowest body weight
category attenuated after excluding subjects exhibiting at least one of the indicators of
disease-related weight loss.
In table 2.4,1 present the published data from 14 prospective studies that
evaluated the relation between body weight and mortality in analyses that examine the
effect of the early mortality exclusion on the risk due to low body weight. Of the 11
studies of men, all 11 showed that risk due to the lowest body weight category was
attenuated after excluding the early mortality. Of the 8 studies of women, 4 showed a
slight attenuation in risk for the lowest body weight category due to the early mortality
exclusion [Nurses’ Health Study (39); Adventist Mortality Study, ages 30-54 years (21);
Framingham Heart Study (67); Established Populations for Epidemiologic Studies of the
Elderly (11)], and of these it was only the studies of middle-aged women [Nurses’ Health
Study (39); Adventist Mortality Study, ages 30-54 years (21)] in which the risk
attenuated to a protective association.
Taken together, the findings in tables 2.3-2.4 provide evidence that exclusion of
subjects with baseline indicators of disease-related weight loss (diagnosed disease,
physical complaints, weight loss, early mortality) tends to particularly attenuate risk due
to low body weight among men and middle-aged women. That this effect was either less
pronounced or absent among older women raises two possibilities: 1) a true causal
association between low body weight and increased mortality risk exists among older
11

women; 2) the early mortality exclusion is not entirely effective in excluding the older
women who were lean due to life-threatening disease.

Confounding by Other Variables

A few studies have raised the possibility that some of the apparent increase in risk
due to low body weight may be due to confounding by alcohol use. Stamler et al
(40) reported an increased risk of mortality among lean hypertensives, but also found a
high prevalence of alcohol use among the lean hypertensives. Also, recent findings from
Japanese-American men of the Honolulu Heart Study (13) suggest that among those lean
men exhibiting excessive alcohol use, the calories from alcohol use may be replacing the
calories from other sources, and thus among these men, low BMI might be an indicator of
a “low nutrient intake” state that itself may be a causal factor. Among German
construction workers, Brenner et a/ (33) has recently reported an inverse relation between
BMI and mortality that persists after control of smoking, exclusion of the early mortality,
and exclusion of pre-existing illness. It is noteworthy, however, that daily alcohol
consumption was highly prevalent among these men (90% consumed > 1 gram/day; 40%
consumed >50 gram/day), thus raising the possibility that residual confounding remained
even after multivariate adjustment for alcohol intake. Taken together, these data suggest
that the body-weight mortality relation should be evaluated after accounting for excessive
alcohol use.
The NHANES I cohort was assembled by a sampling of the US population in
1971-1975, in which a modest oversampling of subjects who were living below the
poverty level has been identified (43). I am aware of two published analyses of the
NHANES I cohort that have used this characteristic of the population to stratify the
analysis on “poverty level” to determine whether this factor impacted the relation
12

between body weight and mortality. Tayback et a/ (14) have reported a substantially
higher death rate for a BMI of < 19 kg/m2 among the “poor” (7.5 per 100 person-years)
as compared to the “non-poor” (3.5 per 100 person-years). Rumpel et a/ (10) has
reported that weight loss of > 8.55% of body weight, was a stronger risk factor among the
lean poor as compared to the lean non-poor. These data from the NHANES I cohort raise
the possibility that in a general population sample some of the effects of low body weight
may be attributable to a spectrum of causal exposures associated with poverty (nutritional
factors, psychosocial factors, decreased access to medical care). Brownell et al (\ 12)have
raised the possibility that some of the psychological stresses associated with poverty may
produce a pattern of weight cycling (large changes in body weight) that itself may be
causal. Thus, complex effects of poverty, low body weight, and weight fluctuation may
also be possible.

Recommendations for Control of Confounding in a Prospective Study ofBody Weight in
relation to Mortality

The findings from the studies reviewed in Tables 2.1, 2.3, and 2.4 of this chapter
provide good evidence that the relation between body weight and mortality can be
confounded by cigarette smoking and disease-related weight loss. I have presented
arguments in this chapter that form the basis for the following set of recommendations for
the control of confounding by these variables when conducting a prospective study.
•

Confounding by cigarette smoking can be effectively controlled by excluding
subjects with any history of cigarette smoking.

•

Confounding by disease-related weight loss can be studied by exploring a possible
time-dependency whereby the risk due to low body weight is especially
pronounced during the early follow-up. In the presence of such time dependency,
13

the confounding can be controlled by excluding the period during which this
increased risk occurs.
•

Confounding by disease-related weight loss can be partly controlled by
excluding subjects with putative indicators of baseline disease (disease history,
symptom history, recent weight loss).

There is limited evidence that confounding of the body weight-mortality relation by other
lifestyle factors (poverty, alcohol use) may also be important in studies of those
populations with a high prevalence of lifestyle factors that contribute to unintentional
weight loss.

Relation between BMI and Mortality among Apparently Healthy Non- or Never-smokers:
A Summary of the Current Evidence

In the previous section, I provided a set of recommendations for the control of
confounding by cigarette smoking and disease-related weight loss when examining the
relation between body weight and mortality among adults. These recommendations imply
that the most informative study of the body weight-mortality relation would include an
analysis with exclusions of cigarette smokers and those with presumptive indicators of
baseline disease (death during the early follow-up, pertinent disease or symptom history).
Therefore, in this section I have used these recommendations to select a group of studies
that include these exclusion criteria and reviewed the findings from these studies.
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Selection ofStudies

I conducted a search of the National Library of Medicine databases that identified
86 published studies in which a measure of adiposity (i.e. BMI, relative weight) was
related to the subsequent risk of mortality. I then selected for further consideration
studies of non-Hispanic whites that included an analysis in which there was a
simultaneous exclusion of smokers and the early mortality. The rationale for this further
selection of non-Hispanic whites is the accumulated evidence that the body weightmortality relation may be different among non-whites (12,51,52,100), and the paucity of
data from large samples of non-whites that included an analysis with the exclusions given
above. For the situation in which multiple published analyses were available for a given
study population, the study that excluded the largest group of smokers (i.e. current and
former rather than current) and the longest duration of follow-up was summarized in
detail.
Thus, after applying the selection criteria given above, I identified eleven
published studies of non- or never-smoking adults that have examined the relation
between body weight and mortality in an analysis with an early mortality exclusion
(20,21,30,38,39,45,47,49,57,64,67). The major findings from each study and
characteristics of the study population used are given in tables 2.5-2.7.

Summary ofSelected Studies

In table 2.5,1 have summarized the findings from those prospective studies of
BMI and mortality that have included an analysis that excludes smokers and the early
mortality (20,21,30,38,39,45,47,49,57,64,67). Of the studies in table 2.5 reporting a Jor U-shaped relation between BMI and mortality, most of the age-gender subgroups
15

studied tended to be older women. In contrast, of the studies in table 2.5 reporting an
approximately positive relation (direct or J-shaped with nadir < average BMI for the
study population) between BMI and mortality, most of the subgroups studied tended to be
in an age-gender classification other than older women (i.e. middle-aged women, men).
Thus, the accumulated data raise the possibility that the BMI-Mortality relation is
dependent on age and gender.

Summary of the Findings by Age and Gender

To further evaluate this possibility, I have summarized the findings from the
studies in table 2.5 by gender and age at baseline in table 2.6 (women) and table 2.7
(men). A discussion of the findings for each age-gender subgroup is given below.
Middle-aged Women (Body Weight reported before age 55 years). Of the three
studies of middle-aged women in table 2.6, an approximately positive relation is evident
after 12-14 years of follow-up in all three populations. In the Adventist Mortality Study,
however, follow-up of 30-54 year-old women surviving 15-26 years after the report of
body weight revealed a J-shaped relation. It is noteworthy that the long-term follow-up of
these women produces a range of age attained during the follow-up of 45-80 years. Thus,
if one assumes that body weight remained relatively stable between baseline and year 15,
then the findings from long term follow-up of middle-aged women should be more
similar to findings from short-term follow-up of older women.
Older Women (Body Weight reported at age 55 years or older). Of the five
studies of older women in table 2.6, the relation between BMI and mortality in 9 out 10
of the subgroups (by age and follow-up time) was predominantly U- or J-shaped with a
nadir at or above the average BMI. In the 15-26 year subgroup of the Adventist Mortality
Study, however, a direct positive relation was reported. These data raise the possibility
16

that the substantially longer follow-up for the 15-26 year subgroup of the Adventist
Mortality Study may have contributed to a difference in the BMI-Mortality relation that
was observed. Possible explanations for this difference that occurs with long-term
follow-up include but are not limited to the following. First, if the bias due to diseaserelated weight loss persists for up to 14 years among older women, then only exclusion of
the first 14 years of follow-up would attenuate the risk. Second, among the apparently
healthy lean older women risk there may be co-morbid factors that increase risk at the
fifth to the seventh decade.
Middle-aged and Older Men. Among the studies of men summarized in table 2.7,
I found no apparent differences in the BMI-Mortality relations for middle-aged men as
compared to the older men. Of the seven studies of middle-aged and older men in table
2.7, an approximately positive relation (direct or J-shaped with nadir < average BMI)
between BMI and mortality was evident in 11 out the 16 subgroups based on age and
follow-up time. Among the five remaining, 1 showed risk only for high BMI (NHANES
I), 1 had a low event rate among the high BMI (CPS I, > 85 years), and 3 exhibited a Jshaped relation with a nadir at or above the average BMI (Adventist Mortality Study,
middle-aged at years 9-14; Framingham; Italian Men).
A common feature of the five studies in table 2.7 that did not report a positive
relation with BMI, was that follow-up time was less than 14 years. It is noteworthy that
the three subgroups in table 2.7 with follow-ups greater than 14 years showed direct
positive relations. Moreover the long-term follow-up (> 20 years) data from studies of
men that did not exclude smokers and the early mortality from the analysis(not given in
table 2.7), also indicate a direct positive relation and/or a risk due to obesity that only
became evident during the later follow-up (66,68,98,99).
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Conclusion

Data from published studies of apparently healthy non- or never- smoking adults
raise the possibility that the BMI-Mortality relation may be dependent on age and gender.
The data for middle-aged men, older men, and middle-aged women supports a direct
positive relation, while the data for older women supports a J-shaped relation.
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Table 2.1

O

Data from 13 prospective studies in which the body weight-mortality relation was considered in smoking-status speciflc analyses.
RR for Lowest Weight versus Referent Category*
Current
Former
Never-

Study

Age

Gender

Lowest Weight
Category
versus Referent

NHANES 1 (57)

65-74 years
65-74 years

men
women

< 22 versus 24-26 kg/m2
<21 versus 24-27 kg/mJ

1.7
1.3

1.5
1.0

Nurses Health Study (39) 30-54 years

women

< 19 versus 25-27 kg/m2

1.4

2

smoker

smoker

0.9

1.7

1.3

1.1

0.9

0.9

1.3

1.1

1.2

Total

smoker

College Alumni (45)

30-54 years

men

< 23 versus 24-25 kg/m

British Men (64)

40-59 years

men

20-21 versus 22-23 kg/m2t

1.3

0.7

Italian Men (47)

30-69 years

men

18 versus 28 kg/m2

1.7

1.6

Iowa Women (49)

55-69 years

women

< 23 versus 23-25 kg/m2

Dutch Adults (38)

30-54 years

men

< 19 versus 19-25 kg/m2

Finnish Women (56)

25-64 years

women

1.1

<

2.6

<--

1.6.............. >

< 22 versus 22-24 kg/m2

1.4

1.5

1.9

1.1
1.2
1.2
1.2
1.2
1.2
1.2
1.2
1.2
1.2

1.3

<
<—
<
<
<
<
<
<

American Cancer Society CPS 1(113):
40-49 years
50-59 years
60-69 years
70-79 years
80-89 years
40-49 years
50-59 years
60-69 years
70-79 years
80-89 years
American Cancer
Society CPS II (97):
> 30 years
> 30 years

men
men
men
men
men
women
women
women
women
women

<80 versus 90-109% MRW§
<80 versus 90-109% MR W
<80 versus 90-109% MRW
<80 versus 90-109% MRW
<80 versus 90-109% MRW
<80 versus 90-109% MRW
<80 versus 90-109% MRW
<80 versus 90-109% MRW
<80 versus 90-109% MRW
<80 versus 90-109% MRW

women
men

<80 versus 90-104% MRW
<80 versus 90-104% MRW

Albany Study (98)

38-55 years

men

80-89 versus 100-109% MRW

Kaiser Permanente (99)

40-79 years
40-79 years

men
women

> 25 years

men

Finnish Men (65)J
*
t
|
§

1.0
1.1
1.1
1.)
1.1
1.2
1.2
1.1

>

1.42.6
0.9

>

1.0-

-- 1.2........... >
>
1.3>
-- 1.4-->
-- 1.2>
-- 1.2-->
1.4>
1.1
1.2-

>
1.6<............ 1.5................>

1.5
1.4

1.0

<

1.1

< 22 versus 24-26 kg/m2
< 20 versus 22-23 kg/m2

1.5
1.7

0.9

1.0

1.1
0.9

2.4

< 19 versus 22-25 kg/m2

1.9

1.8

1.8

2.3-3.6

<

RR= Risk Ratio. RRs given in italics were estimated from a plot given in the published report.
< 5 deaths for the lowest weight category (< 20 kg/m2).
referent category for never, former, and current smoker was 22-25 kg/m2 among the never-smokers.
MRW - relative weight from the height-weight tables of the Metropolitan Life Insurance Company.

>

0.7-

1.3

Table 2.2

Exclusion criteria to be used to control for confounding by pre-existing illness when examining the relation betw een body weight and

mortality in a prospective study.
•

subjects with a diagnosis of coronary heart disease, cancer, stroke at
baseline
disease-free subjects at baseline who exhibit (or report) symptoms
consistent with undiagnosed disease

ro

disease-free subjects at baseline who experience large weight loss shortly

o

before and/or shortly after baseline

Table 2.3
Data from 8 prospective studies in which the body weight-mortality relation was considered in analyses that allowed for comparison of
the risk estimates after exclusion of subjects with baseline indicators of disease-related weight loss.

Gender

Lowest
Weight
Category
versus Referent

Indicator
of Disease at
Baseline

RR for Lowest Weight
versus Referent Category*:
Exclusion of
subjects with the
Total
Indicator

Nurses Health Study (39) 30-54 years

women

< 19 versus 25-27 kg/m2

non-stable weight

0.9

0.8

Iowa Women (49)

55-69 years

women

< 23 versus 25-27 kg/m2

cancer, heart disease

1.3

0.8

30-54 years
55-74 years
30-54 years
55-74 years

men
men
women
women

< 23 versus 23-27 kg/m2
< 23 versus 23-27 kg/m2
<21 versus 23-25 kg/m2
< 21 versus 23-25 kg/m2

symptoms
symptoms
cancer, heart disease, symptoms
cancer, heart disease, symptoms

1.6
1.0
1.7
2.0

1.3
0.8
1.2
2.1

Italian Men (47)

30-69 years

men

18 versus 28 kg/m2

cancer, heart disease, diabetes

1.8

1.9

British Men (64)

40-59 years

men

<20 versus 22-23 kg/m2

bronchitis, asthma, ulcer, CHD

1.8

1.6

German Construction
Workers (33)

25-64 years

men

< 23 versus 25-27 kg/m2

diabetes, CHD, hypertension

1.4

1.3

Established Populations
for Epidemiologic Studies
of the Elderly (11)
70-103 years
70-103 years

men
women

< 22 versus 24-26 kg/m2
<21 versus 24-26 kg/m2

cancer, heart disease, diabetes, hip fracture 1.2
cancer, heart disease, diabetes, hip fracture 1.3

1.3
1.3

Finnish Men (65)

men

< 19 versus 22-25 kg/m2

cancer, heart disease, or weight loss

1.2

Stud’

Adventist Mortality
Study (20,21)

hO

*RR= Risk Ratio.

Age

25-54 years

1.9

Table 2.4

Data from 14 prospective studies in which the body weight-mortality relation was considered in analyses that allowed for comparison
of the risk estimates after the early mortality exclusion.
Excluding
the Early
Mortality
1.0
1.4

65-74 years
65-74 years

Gender
men
women

Nurses Health Study (39) 30-54 years

women

< 19 versus 25-27 kg/m2

4

0.9

0.8

College Alumni (45)

30-54 years

men

< 23 versus 24-25 kg/m2
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1.3

1.0

30-54 years
55-74 years
30-54 years
55-74 years

men
men
women
women

< 23 versus 23-27 kg/m2
< 23 versus 23-27 kg/m2
< 21 versus 23-25 kg/m2
< 21 versus 23-25 kg/m2

14
14
14
14

65 years
65 years

women
men

< 23 versus 23-25 kg/m2
< 23 versus 23-25 kg/m2

4
4

1.7
1.4

women

< 23 versus 25-27 kg/m2

2

1.3

1.3

men

18 versus 28 kg/m2

1.3

Stud'
NHANES I (57)

Adventist Mortality
Study (20,21)

Framingham (67)
to
to

7
7

RR for Lowest Weight
versus Referent Category:
During the
Early
Total
Mortality
1.3
1.4

Lowest
Weight
Category
versus Referent
< 22 versus 24-26 kg/m2
< 21 versus 24-27 kg/m2

Iowa Women (49)
Italian Men (47)

Age

55-69 years
30-69 years

Duration of
Early Mortality
Exclusion*

0.7, 1.6t
1.0,0.7t
1.8, 1.2t
2.0, 1.3t

1.1
0.9

3.0
2.3

1.5
1.3

0.9
0.8

5

1.8

Finnish Women (56)

25-64 years

women

< 22 versus 22-24 kg/m2

7

1.4

Finnish Men (65)

25-54 years

men

< 22 versus 22-25 kg/m2

7

British Men (64)

40-59 years

men

<20 versus 22-26 kg/m21

2

4.0

1.6

Dutch Men (38)

30-54 years

men

< 19 versus 19-25 kg/m2

5

1.6

t

Albany Study (98)

38-55 years

men

80-99 versus 100-109% MRW
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1.4

1.0

men
women

decile 1 versus deciles 4-5
decile 1 versus deciles 4-5

10
10

men
women

< 22 versus 24-26 kg/m2
<21 versus 24-26 kg/m2

3
3

Kaiser Permanente (99) 40-79 years
Established Populations
for Epidemiologic Studies
of the Elderly (11)
70-103 years
70-103 years

*
t

l

A period from starting from baseline and extending through the early follow-up.
Multiple early study periods
no deaths among men < 19 kg/m2 remained after excluding the early mortality

1.3

1.7

1.3

1.2

1.1 to4.lt
0.7 to 1.9t
1.2
1.3

0.8

1.3
1.0
1.2

Table 2.5

Prospective studies of adults that relate BMI to all-cause mortality in analyses that exclude smokers and deaths occurring during the
early follow-up: Classified by BMI-Mortality Relation.
Duration of

U)

follow-up after
exclusion of the BMI-

Gender

Age at
Baseline

early mortality mortality relation

never-smoker
non-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
non-smoker
never-smoker
non-smoker

Women
Women
Women
Women
Women
Women
Women
Women
Men
Men
Men

55-69 years
65 years
65-74 years
25-64 years
55-74 years
55-74 years
30-54 years
75-84 years
65 years
30-54 years
30-69 years

3-5 years
4-19 years
7-12 years
7-16 years
5-8 years
9-14 years
15-26 years
2-12 years
5-13 years
9-14 years
6-10 years

U-shaped ,nadir at 25-27 kg/mJ
J shaped, nadir at 24-26 kg/m2
U-shaped, nadir at 24-27 kg/m2
U-shaped, nadir at 23-25 kg/m2
U-shaped, nadir at --24 kg/m2
U-shaped, nadir at -24 kg/m2
J-shaped, nadir at ~22 kg/m2
U-shaped .nadir at 25-27 kg/m2
J-shaped nadir at 23-25 kg/m2
J-shaped, nadir at 23-27 kg/m2!
U-shaped, nadir at 26 kg/m2

never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
non-smoker

Women
Women
Women
Women
Women
Women
Women
Men
Men
Men
Men
Men
Men
Men
Men
Men
Men
Men

30-54 years
30-54 years
55-74 years
30-44 years
45-54 years
55-64 years
65-74 years
40-59 years
47 years (mean)
30-54 years
55-74 years
55-74 years
30-44 years
45-54 years
55-64 years
65-74 years
75-84 years
30-54 years

4-12 years
9-14 years
15-26 years
2-12 years
2-12 years
2-12 years
2-12 years
3-9 years
6-27 years
15-26 years
9-14 years
15-26 years
2-12 years
2-12 years
2-12 years
2-12 years
2-12 years
6-12 years

direct, minimum < 19 kg/m2
direct, minimum < 21 kg/m2
direct .minimum <21 kg/m2
direct, minimum -19 kg/m2
direct, minimum < 19 kg/m2
direct, minimum < 25 kg/m2
J-shaped, nadir at 19-22 kg/m2
J-shaped, nadir at 20-22 kg/m2
direct, minimum < 23 kg/m2
direct, minimum 14-23 kg/m2
direct, minimum 14-23 kg/m2
direct, minimum 14-23 kg/m2
direct, minimum < 22 kg/m2
direct, minimum < 19 kg/m2
direct, minimum < 19 kg/m2
J-shaped, nadir at 19-22 kg/m2
J-shaped, nadir at 19-22 kg/m2
direct, no deaths for < 18.5 kg/m2; t risk for > 25 kg/m2

never-smoker
never-smoker
never-smoker
* American Cancer Society, Cancer Prevention Study I

Women
Men
Men

> 85 years
> 85 years
65-74 years

2-12 years
2-12 years
7-12 years

t risk < 19 versus 19-22 kg/m2; no association for > 22 kg/m2
no relation (< 5 subjects per category at > 29 kg/m2)
t risk for > 29 versus 24-26 kg/m2; no relation for < 24 kg/m2

Study

K)

Smoking
Status

J- or U-shaped Relation
with nadir > average
Iowa Women (49)
Framingham (67)
NHANES 1 (57)
Finnish Women (56)
Adventist Mortality Study (21)
Adventist Mortality Study (21)
Adventist Mortality Study (21)
CPS I* (30)
Framingham (67)
Adventist Mortality Study (20)
Italian Men (47)
Direct Positive or J-shaped
Relation with nadir < average
Nurses’ Health Study (39)
Adventist Mortality Study (21)
Adventist Mortality Study (21)
CPS I (30)
CPS I (30)
CPS 1 (30)
CPS 1 (30)
British Men (64)
College Alumni Study (45)
Adventist Mortality Study (20)
Adventist Mortality Study (20)
Adventist Mortality Study (20)
CPS 1 (30)
CPS I (30)
CPS I (30)
CPS I (30)
CPS I (30)
Dutch Adults (38)
Other
CPS I (30)
CPS I (30)
NHANES 1 (57)

Table 2.6
Prospective studies of middle-aged and older women that relate BMI to all-cause mortality in analyses that exclude smokers and death
occurring during the early follow-up.

Study

K)

Middle-aged
Women*
CPS IJ (30)
CPS I (30)
Nurses’ Health Study (39)
Adventist Mortality Study (21)
Adventist Mortality Study (21)
Older
Woment
Iowa Women (49)
Framingham (67)
NHANES I (57)
Adventist Mortality Study (21)
Adventist Mortality Study (21)
Adventist Mortality Study (21)
CPS I (30)
CPS 1 (30)
CPS I (30)
CPS I (30)

Smoking Status

Excludes
Baseline
Chronic
disease?

Excludes
indicators
of pre-existing
disease?

never-smoker
never-smoker
never-smoker
never-smoker
never-smoker

Yes
Yes
Yes
Yes
Yes

never-smoker
non-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker

never-smoker

Age at
Baseline

Duration of
follow-up after
exclusion of the
early mortality

Range of
Age attained
during the
follow-up

BMImortality relation

Yes
Yes
Yes
Yes
Yes

30-44 years
45-54 years
30-54 years
30-54 years
30-54 years

2-12 years
2-12 years
4-12 years
9-14 years
15-26 years

32-56 years
47-66 years
34-66 years
39-68 years
45-80 years

direct, minimum at -l 9 kg/m?
direct, minimum < 19 kg/m^
direct, minimum < 19 kg/m^
direct, minimum <21 kg/m?
J-shaped, nadir at -22 kg/m?

Yes
No
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes

No
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes

55-69 years
65 years
65-74 years
55-74 years
55-74 years
55-74 years
55-64 years
65-74 years
75-84 years
>85 years

3-5 years
4-19 years
7-12 years
5-8 years
9-14 years
15-26 years
2-12 years
2-12 years
2-12 years
2-12 years

58-74 years
69-84 years
72-86 years
60-82 years
69-88 years
70-100 years
57-76 years
68-86 years
77-96 years
87->96 years

U-shaped,nadir at 25-27 kg/m?
J shaped, nadir at 24-26 kg/m?
U-shaped, nadir at 24-27 kg/m?
U-shaped, nadir at -24 kg/m?
U-shaped, nadir at -24 kg/m?
direct .minimum < 21 kg/m?
direct, minimum < 25 kg/m?
J-shaped, nadir at 19-22 kg/m?
U-shaped ,nadir at 25-27 kg/m?
t risk < 19 versus 19-22 kg/m?; no association for
> 22 kg/m?

Yes

No

25-64 years

7-16 years

32-80 years

U-shaped, nadir at 23-25 kg/m?

Middle-aged

+
Older Women
Finnish Women (56)

*Body weight reported before age 55 years
fBody weight reported at age 55 years or older
t American Cancer Society, Cancer Prevention Study I

Table 2.7
Prospective studies of middle-aged and older men that relate BMI to all-cause mortality in analyses that exclude smokers and deaths
occurring during the early follow-up.
Excludes Excludes
Baseline indicators
Chronic of pre-existing
disease? disease?

Age at
Baseline

Duration of
follow-up after
exclusion of the
early mortality

Range of
Age attained
during the
follow-up

3-9 years

Study

Smoking Status

British Men (64)
College Alumni Study (45)
Dutch Adults (38)

never-smoker

No

Yes

never-smoker
non-smoker

Yes
No

No
No

40-59 years
47 years (mean)
30-54 years

6-27 years
6-12 years

43-68 years
53-74 years
36-66 years

Adventist Mortality Study (20)
Adventist Mortality Study (20
CPS IJ (30)
CPS I (30)

never-smoker
never-smoker
never-smoker
never-smoker

No
No
Yes
Yes

Yes
Yes
Yes
Yes

30-54 years
30-54 years
30-44 years
45-54 years

9-14 years
15-26 years
2-12 years
2-12 years

39-68 years
45-80 years
32-56 years
47-66 years

Framingham (67)
NHANES I (57)

non-smoker
never-smoker

No
No

Yes
No

65 years
65-74 years

5-13 years
7-12 years

70-88 years
72-86 years

Adventist Mortality Study (20)
Adventist Mortality Study (20)
CPS I (30)
CPS I (30)
CPS I (30)
CPS I (30)

never-smoker
never-smoker
never-smoker
never-smoker
never-smoker
never-smoker

No
No
Yes
Yes
Yes
Yes

Yes
Yes
Yes
Yes
Yes
Yes

55-74 years
55-74 years
55-64 years
65-74 years
75-84 years
> 85 years

9-14 years
15-26 years
2-12 years
2-12 years
2-12 years
2-12 years

64-88 years
70-100 years
57-76 years
67-86 years
77-96 years
87- >96 years

Italian Men (47)
non-smoker
Yes
*Body weight reported before age 55 years
fBody weight reported at age 55 years or older
} American Cancer Society, Cancer Prevention Study I

No

30-69 years

6-10 years

36-79 years

BMImortality relation

Middle-aged
Men*

to

J-shaped, nadir at 20-22 kg/m2
direct (minimum < 23 kg/m?)
direct, no deaths for < 18.5 kg/m?;
(risk for > 25 kg/m?
J-shaped, nadir at 23-27 kg/m??
direct (minimum 14-23 kg/m?)
direct, minimum < 22 kg/m?
direct, minimum < 19 kg/m?

Older
Men?

Middle-aged
+
Older Men

J-shaped (nadir at 23-25 kg/m?)
( risk for > 29 versus 24-26 kg/m?;
no relation for < 24 kg/m?
direct (minimum 14-23 kg/m?)
direct (minimum 14-23 kg/m?)
direct (minimum < 19 kg/m?)
J-shaped (nadir at 19-22 kg/m?)
J-shaped (nadir at 19-22 kg/m?)
no relation (< 5 subjects per category at
29 kg/m?)

U-shaped, nadir at 26 kg/m2

CHAPTER 3
STUDY I: BODY MASS AND 26-YEAR RISK OF MORTALITY FROM SPECIFIC
DISEASES AMONG WOMEN WHO NEVER SMOKED: FINDINGS FROM THE
ADVENTIST MORTALITY STUDY

Preface to the Manuscript

Study I continues the investigation of body weight and mortality among neversmoking women of the Adventist Mortality Study by considering the contribution from
specific diseases to the increase in risk due to high BMI among all women, and the
increase in risk due to low BMI among older women. Study I is presented in the form of a
formatted manuscript that has been published in the journal Epidemiology (1998; 9:246254) and is reproduced here along with the accompanying editorial (Appendix, Editorial
Comment for Study I).
In Chapter 2,1 have presented a set of recommendations for the control of
confounding by cigarette smoking and disease-related weight loss when evaluating the
relation between body weight and mortality. These recommendations have been applied
to Study I and resulted in the use of the following methods: 1) exclusion of current and
former smokers from the analysis, 2) an early mortality exclusion with an « of up to 14
years, and 3) subgroup analyses that excluded subjects with chronic disease history (heart
disease, stroke, cancer) and weight loss.
The 26-year follow-up (1960-1985) of the Adventist Mortality Study population
in Study I overlaps with 12-year follow-up of the Adventist Health Study (1976-1988) in
Study II and produces a subgroup who were simultaneously followed by both studies
from 1976 to 1985. It is noteworthy that the mortality surveillance efforts of the two
studies used different nosologists for obtaining cause of death. This allows for a
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reliability analysis of the cause of death data that is presented in the Appendix
(Reliability Analyses on Methods of Nosology).
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Body Mass and 26-year risk of Mortality from Specific Diseases Among Women Who
Never Smoked: Findings from the Adventist Mortality Study
(reproduced with permission from Singh PN, Lindsted KD. Body Mass and 26-year Risk
of Mortality from Specific Diseases among Women Who Never Smoked. Epidemiology
1998; 9: 246-254).
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Abstract
We examined the relation between Quetelet's body mass index (BMI) and age-adjusted
mortality risk from specific diseases in a 26-year prospective cohort study of 12,576 nonHispanic white, never-smoking women. To account for effects due to antecedent disease,
we focused on women surviving 15-26 years after their report of body weight. High BMI
(> 27 kg/m2) decreased risk of fatal respiratory disease (hazard ratios of 0.7 for ages 3054 years and 0.6 for ages 55-74 years), but increased risk in all other disease categories.
Low BMI (< 21 kg/m2) increased risk of fatal respiratory disease (hazard ratios of 2.0 for
ages 30-54 years and 1.4 for ages 55-74). Among middle-aged women (ages 30-54
years), we found that low BMI also increased risk of certain fatal cardiovascular diseases
(hazard ratios of 1.5 for cerebrovascular death and 2.5 for hypertensive + other
cardiovascular deaths), but that the increase in risk of fatal cerebrovascular disease did
not remain (hazard ratio of 0.4) after exclusion of subarachnoid and intraparenchymal
hemorrhage deaths from the endpoint.
Although the inverse relation between BMI and risk of fatal respiratory disease
was also evident in the subset who reported body weight 17 years after baseline, further
restriction of this subset to stable weight women reporting no history of respiratory
disease resulted in a U-shaped relation. Data from the subset also indicated that weight
loss substantially increased risk of fatal respiratory disease. These findings implicate
high and low BMI as risk factors for fatal respiratory disease, but suggest that the risk due
to high BMI was obscured by weight loss that followed the onset of disease.
The overall findings support an association between obesity and a higher risk of
fatal disease, but also raise the possibility that apparently healthy, never-smoking women
can experience a higher long-term risk of fatal cardiovascular and respiratory diseases due
to a lower body weight.
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Introduction
The commonly found association between overweight and excess cardiovascular
disease mortality risk among women1'8 has been attributed to elevations in blood pressure,
hypercholesteremia, and glucose intolerance among those of higher body weight, though
an independent association with overweight after controlling for such factors has
frequently been shown4,6'9. Excess hormone-related cancer mortality (breast, ovary,
uterus) among overweight women has been attributed to a possible causal pathway
involving the conversion of androgens to estrogens in the adipose tissue10'13. The
possibility of a relation between leanness and a higher mortality risk remains
controversial.

In past studies, the inadequate control of confounding by smoking and

antecedent illness has often precluded an evaluation of this effect9.
In this report, we have examined the relation between Quetelet’s body mass index
(BMI) and the 26-year risk of mortality from specific diseases among non-Hispanic
white, never-smoking women from the Adventist Mortality Study (AMS). The relation
between BMI and all-cause mortality among these women has been reported 14. During
15-26 years of follow-up, a J- shaped relation among middle-aged women (median
attained age, 68 years) and a positive linear relation among older women (median attained
age, 87 years) were identified. A J- or U- shaped BMI-Mortality relation has been shown
in other populations in which obesity-related disease (cardiovascular, cancer, diabetes
mellitus) contributed to excess mortality risk among those of higher BMI, while
respiratory, hypertensive, and digestive diseases contributed to excess mortality risk
among those of lower BMI15,16. This latter effect has been attributed to the effects of
smoking, alcohol use, and disease-related weight loss among lean subjects9,15,16. Among
never-smoking middle-aged women of the AMS cohort, however, a J-shaped relation
between BMI and all-cause mortality persists even after accounting for each of these
other factors 14. Thus, the findings among never-smoking women of the AMS cohort
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raise the possibility of a causal relation between low body weight and disease-related
mortality.
In the present study of never-smoking women of the AMS cohort, we determined
the relation between BMI and mortality risk from cardiovascular diseases (all, ischemic
heart disease, cerebrovascular, hypertensive + other), cancers (all, hormone-related), and
other diseases (all, respiratory disease) to evaluate whether linear and non-linear all-cause
mortality trends observed in this cohort are consistent with plausible pathophysiologic
mechanisms by which high and low body weight can increase risk of specific fatal
diseases. By church proscription, Seventh-day Adventists are characterized by very little
smoking and alcohol use, and a large proportion of members adhere to a lacto-ovo
vegetarian diet17. Therefore, among the never-smoking women of the AMS cohort
studied here, the low prevalence of traditional risk factors for chronic disease provides a
unique opportunity to examine the independent effect of BMI on fatal disease among
women.
Methods
Study Population
In 1960, 27,530 California Seventh-day Adventists aged 30 years or older
completed a four-page American Cancer Society questionnaire1 which included items on
demographic, medical, dietary, and lifestyle characteristics. The details of this population
have been described previously (14,18). Of the total female respondent population,
16,946 (97%) had complete birth year information and were used in the present study.
We used computer assisted record linkage with the California Death Certificate
File, church membership records, and telephone contact with close relatives to ascertain
death during the 26 years of follow-up (1960-1985). In sub-studies described
previously14,18, the record linkage procedure identified 94% of all deaths in a random
sample (n=600) of study subjects.
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In the female respondent population, there was not a sufficient number of non
whites, current smokers, past smokers or subjects of age 75 years or older to allow for
separate analyses of each group. Since the impact of BMI on mortality might vary across
these groups19,20, we restricted the analysis to never-smoking, non-Hispanic white women,
age 30 to 74 years, n=l2,576.
Data Analysis
We defined three major study endpoints: mortality from cardiovascular disease
(ICD-9: 390-398, 400-404, 410-414, 420-429, 430-438, 440-458), cancer (ICD-9: 140239), and all other fatal disease. In certain analyses, we considered mortality endpoints
for ischemic heart disease (ICD-9 410-414), cerebrovascular disease (ICD-9 430-438),
hypertensive + other cardiovascular disease (ICD-9 400-404, 420-429,440-458), hormone
related cancers (ICD-9 174, 179, 180, 182, 183) and respiratory diseases (ICD-9 460494, 496,510-519). Subjects who died from poisonings, accidents, and congenital
malformations (537 deaths; ICD-9: 740-759, 800-999) contributed person-time until the
year of death, but we did not include these deaths in the mortality endpoints. We
calculated BMI (Quetelef s, kg/m2) from the height (without shoes) and weight (in indoor
clothing) values that subjects reported on the baseline questionnaire. For the analysis, we
categorized BMI into quintiles as follows: I, < 21.3 kg/m2; II, 21.3-22.9 kg/m2; III, 2324.8 kg/m2; IV 24.9-27.4 kg/m2; V, > 27.4 kg/m2.
We used baseline questionnaire data to define, a priori, three baseline indicators of
pre-existing illness: recent weight loss, severe physical complaints, disease history 1,14,21,22
Recent Weight Loss was defined as a loss of greater than 10 lbs. occurring during the five
year interval prior to baseline (loss occurring prior to this interval was not included).
Severe Physical Complaints was defined as a baseline report of currently experiencing at
least one of the following "severe" complaints: chest pain, shortness of breath, blood in
stool, blood in urine, lump or thickening in breast, unusual discharge from breast, unusual
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bleeding from vagina, fatigue, loss of appetite. Disease History was defined as a baseline
report of heart disease, cancer (all sites), or stroke history. We examined the impact of
pre-existing illness on the BMI-Mortality relation by evaluating changes in the relation
after exclusion of women exhibiting one or more of the baseline indicators defined above.
To determine the mortality risk among "underweight" and "overweight" women
we computed disease-specific hazard ratios for BMI quintiles I (< 21.3 kg/m2) and V (>
27.4 kg/m2) relative to quintiles II-IV from a Cox proportional hazard model with time on
study as the time variable. All models included a continuous, log-transformed variable
for age at baseline. Alcohol use, dietary pattern, current marital status, and education
level, all previously defined14, were evaluated in larger models. We used methods
described by Woodward23 to retain subjects with missing data in the analysis. The non
response rate was 8% for BMI, 5% for alcohol use, 1 % for current marital status, and 1%
for education level.
We added product terms for BMI quintile x (time on study) to disease-specific
models (cardiovascular, cancer, other) to evaluate the model assumption for the 26-year
follow-up. Risk estimates from these models indicated non-proportional hazards for BMI
Quintiles I and V across four sequential categories of time on study. Specifically, for
BMI Quintile I, excess risk was evident during the first eight years of follow-up, but risk
for this BMI category was either attenuated or protective during the remainder of the
follow-up. For BMI Quintile V, excess risk was generally evident throughout follow-up,
but the magnitude of the effect decreased over time.
To account for non-proportional hazards in further analysis, we divided the 26year follow-up period into four smaller study periods (years 1-8, 9-14, 15-19, 20-26) of
approximately equal person-years where the hazard ratios for BMI within each study
period were not dependent on follow-up time. Within each study period, effect
modification of the ratio measure by age at baseline was further evaluated by considering
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middle-aged (age 30-to-54-years) and older women (55-to-74-years) in separate analyses.
Thus, for each mortality endpoint, we estimated multivariate hazard ratios for BMI
quintiles I and V were from eight models for each of the two age-specific groups in each
of the four study periods.
Using indicator variables to estimate risk for three BMI categories (quintile I, IIIV,V) assumes that there is no variation in risk within each category24. To preserve the
within-category variation in risk for our analyses, we determined hazard ratios for BMI
after replacing the indicator variables for BMI in each model with terms for an
unrestricted quadratic spline function of the continuous BMI variable. Model
specifications are provided in the Appendix.
RESULTS
We identified 1,962 cardiovascular disease deaths, 730 cancer deaths, and 588
deaths from all other diseases during 290,287 person-years of follow-up (1960-1985) of
the 12,576 women in the study population. Among middle-aged (30-to-54-years) and
older (55-to-74-years) women, we have previously reported the frequency or mean value
of selected demographic and lifestyle characteristics by quintile of BMI14. In both age
strata, women of higher BMI were characterized at baseline by less education, a non
vegetarian diet pattern, and a higher prevalence of weight gain, heart disease, diabetes,
and hypertension.
Trends in disease-specific mortality risk versus BMI for years 15-19 and 20-26
were quite similar. Hence, we present an analysis of three study periods (years 1-8, 9-14,
15-26) for middle-aged and older women in Table 1, where each disease-specific model
includes terms for age at baseline, BMI Quintile I, and BMI Quintile V. The only
apparent effect of multivariate adjustment for confounder variables listed above, was an
attenuation in risk of cardiovascular disease mortality for BMI Quintile V after inclusion
of variables for history of hypertension and diabetes. For middle-aged women hazard
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ratios for BMI Quintile V for the three study periods changed from 1.6, 4.7, and 2.6 to
1.0, 3.4,and 1.9. For older women, hazard ratios changed from 1.7, 1.4, and 1.2 to 1.4,
1.2, and 1.2.
Middle-aged Women
During the early follow-up (Table 1), a U-shaped relation between BMI and
mortality from 'other' disease was evident during years 1 to 8, and a more linear relation
was evident during years 9 to 14. Exclusion of women exhibiting some (weight loss,
severe physical complaints) but not all (disease history) indicators of pre-existing illness
markedly attenuated the risk of mortality from 'other' disease among the lean during
years 1 to 8 (HR for Quintile I, V versus II-IV : 1.0, 2.2), but had little effect on the
hazard ratios for years 9 to 14. Thus, excess mortality risk from ‘other disease’ among
the lean during the first 8 years was likely attributable to women who were lean due to
illness at baseline.
During later follow-up (Table 1, years 15-26), the BMI-Mortality relation is of
particular interest since hazard ratios were not substantially altered by exclusion of
women exhibiting any of the three indicators of pre-existing illness (disease-specific
endpoint, HR for Quintile I, V versus II-IV: cardiovascular, 1.8, 2.9; ischemic heart
disease, 1.2, 3.3; cerebrovascular, 2.2, 1.4; hypertensive + other, 3.5, 4.3; cancer, 0.9, 1.3;
hormone-related, 1.5, 1.3; other, 1.2, 1.9; respiratory, 1.4, 0.7; non-respiratory, 1.1, 2.5).
Respiratory disease mortality during years 15-26 was primarily due to pneumonia and
influenza deaths (12 pneumonia and influenza, 9 obstructive pulmonary disease, 4 other
respiratory disease). To examine trends more closely among middle-aged women during
years 15-26, we plotted in Figure 1 (middle-aged women) the fitted risk from an
unrestricted quadratic spline model against a continuous BMI variable.
The overall findings for middle-aged women during years 15-26 (Table 1, Figure
1), indicate that high BMI increased mortality risk in all disease categories except
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respiratory disease, while low BMI increased mortality risk from cerebrovascular disease,
hypertensive + other cardiovascular disease, and respiratory disease. It is noteworthy that
among the normotensive (no history of hypertension in 1960), low BMI remained a risk
factor for cerebrovascular disease (HR for Quintile I, V versus II-IV: 1.7, 1.1) and
hypertensive + other cardiovascular disease (HR for Quintile I, V versus II-IV: 1.9, 1.9 ).
Older Women
During the early follow-up (Table 1), a U-shaped, relation for each endpoint was
evident during years 1 to 8, but the trends for cardiovascular and cancer mortality reduced
to direct relations during years 9 to 14. Exclusion of women reporting severe physical
complaints or weight loss at baseline attenuated the excess cancer mortality risk among
the leanest women (HR for Quintile I, V versus II-IV: 1.2, 1.8) during years 1 to 8, but
exclusion of women with cancer history had little effect. Exclusion of women reporting
any of the baseline indicators of pre-existing illness did not alter other disease-specific
trends during years 1 to 8, or any of the trends observed during years 9 to 14. Thus, some
of the excess cancer mortality risk linked to low BMI during early follow-up may be
attributable to women who were lean due to rapidly fatal cancer, while a true causal
relation between low BMI and mortality risk from the other endpoints (cardiovascular,
other) remains possible.
Similar to the findings for middle-aged women during years 15-26, the BMIMortality among older women of this study period was not altered appreciably by the
exclusion of those exhibiting any baseline indicators of pre-existing illness (disease, HR
for Quintile I, V versus II-IV: cardiovascular, 0.8, 1.2; ischemic heart disease, 0.8, 1.2;
cerebrovascular, 0.9, 1.0; hypertensive + other, 0.6, 1.6; cancer, 1.0, 1.1; hormonerelated, 0.8, 0.5; other, 1.0,1.1; respiratory, 1.4, 0.6; non-respiratory, 0.7, 1.3), and most
respiratory disease deaths were due to pneumonia and influenza (56 pneumonia and
influenza, 15 chronic obstructive pulmonary disease, 13 other respiratory disease).
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During the later follow-up (Figure 1; Table 1, years 15-26), high BMI contributed
to an increase in risk in all major disease categories except respiratory disease, while low
BMI contributed to an increase in mortality risk from respiratory disease.
BMI. Weight Variability, and Respiratory Disease Mortality Among
Women of the Adventist Mortality Study and Adventist Health Study
The inverse relation between baseline BMI (reported in 1960) and 15-26 year
mortality risk from respiratory disease among 30-74 year-old never-smoking women
(n=l 1,130) (Table 1, Figure 1) was also evident in the subset (n=4,307) who reported
body weight in 1976 at enrollment into a 12-year mortality surveillance by the Adventist
Health Study 17. Therefore, to evaluate whether the inverse relation among women of the
subset is reflecting the effects of weight variability during the follow-up period, we
present in Table 2 the relation between percent weight variability [ (1976 body weight) x
100 / 1960 body weight ] and 17-29 year risk of respiratory disease mortality. These data
identify weight loss as a risk factor for fatal respiratory disease and further suggest that
among women with no baseline respiratory disease, risk due to weight loss becomes
especially potent among women of lower baseline BMI (below the mean BMI of 24.6
kg/m2). Also, there is some indication that weight gain decreases risk before onset of
respiratory disease, and increases risk after onset of respiratory disease.
To minimize the effects of baseline respiratory disease and weight variability
during the follow-up on the risk attributable to baseline BMI, we present in Table 3 and
Figure 2 the relation between BMI and mortality risk from respiratory disease after
restriction of the analysis to women with no baseline history of respiratory disease, no
weight gain (>110% of baseline weight at year 17), and no weight loss (< 90% of
baseline weight at year 17). These restrictions reduced the inverse relation among all
women of the subset to a U-shaped relation (Figure 2) and, taken individually, provide
evidence that the protective effect of high BMI among all women is entirely attributable
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to the effects of baseline respiratory disease and weight loss during the follow-up.
DISCUSSION
An elevation in risk of cardiovascular disease mortality for women of BMI greater
than 27 kg/m2 was consistently shown over time and is in concordance with the data from
numerous studies linking obesity to a higher risk of cardiovascular disease mortality 3,4,6,79. Despite the consistent elevation in risk for obese women, the overall relation between
BMI and fatal cardiovascular disease death in the cohort showed strong dependency on
age (Figure 1). Specifically, lean never-smoking older women experienced a small
protection against fatal cardiovascular disease, while lean never-smoking middle-aged
women experienced a higher mortality risk from certain cardiovascular diseases
(cerebrovascular, hypertensive + other). It should be noted that this age-dependency is not
evident among never-smoking, 30-to-74-year-old men of the AMS cohort, among whom
a positive, linear relation with fatal cardiovascular disease is evident throughout
adulthood29. Taken together, these findings raise the possibility of an age and genderrelated etiology that increases the risk of certain fatal cardiovascular diseases among the
lean women of this cohort only during the fifth to seventh decade of life (Figure 1,
attained age 57 to 79 years).
It is noteworthy that this age range where low body weight becomes a risk factor
for fatal cardiovascular disease captures the early post-menopausal mortality experience
of women who were pre- or peri- menopausal when reporting body weight. There is
good evidence to indicate that lean women would likely enter menopause at a lower
estrogen level than their heavier peers30, and thus it follows that ovarian senescence or
ovariectomy would result in an especially low endogenous estrogen level among the
leanest women. Thus, the higher risk of fatal cardiovascular disease among lean women
could involve some of the mechanisms by which lower circulating estrogen level would
increase risk of cardiovascular disease (enhanced atheromatous plaque formation,
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decreased vascular flow, increased blood pressure, increase in low density lipoprotein
levels)31 .
The data, however, provide the additional complexity that low body weight was a
risk factor for some (cerebrovascular disease), but not all (ischemic heart disease) of the
fatal cardiovascular diseases for which estrogen is likely protective. Therefore, adipose
tissue-derived estrogen levels do not entirely explain this effect. Low BMI has been
linked to a higher risk of hemorraghic stroke in a number of populations32'34, and there is
evidence that the lower serum cholesterol levels among those of lower BMI may be
causal35. Further analysis of the AMS women we studied revealed some concordance
with previous findings for this stroke subtype since exclusion of the six deaths from
subarachnoid or intraparenchymal hemorrhage from the cerebrovascular disease endpoint
among middle-aged women (Table 1, years 15-26; Figure 1) reduced the U-shaped
relation to a direct relation (HR for Quintile I,V versus II-IV : 0.4, 2.5). Low BMI has
also been linked to fatal cardiovascular disease among hypertensives, though the relation
has been attributed to cigarette smoking16. Such an effect is unlikely to have occurred
among women we studied, since the analysis was restricted to never-smokers, and low
BMI remained a risk factor among normotensives.
When interpreting the risk factor association for low BMI and fatal cardiovascular
disease, it is important to note that we did not have data available for use of hormone
replacement therapy, body fat distribution, or weight fluctuation during the follow-up.
However, in the subset of never-smoking middle-aged women we studied (Figure 1,
attained age 57 to 79 years) who also provided body weight in 1976 (n=4,307), a Jshaped relation for fatal cardiovascular disease remained among the stable weight women
(90-110% of baseline body at year 17).
A direct relation between BMI and risk of cancer death was evident in this
population and, among middle-aged women, a contribution from fatal hormone-related
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cancers to this effect was identified. These data are consistent with a proposed
mechanism for obesity whereby adipose-derived enzymes catalyze the conversion of
androgens to estrogens10'13, thus promoting carcinogenesis in the female reproductive
organs.
The inverse relation between BMI and risk of fatal respiratory disease among
never-smoking women studied here (Figure 1) should be interpreted with caution when
considering a possible causal role of BMI in the etiology of respiratory disease since
advanced chronic respiratory disease frequently involves loss of body mass28,36-40
particularly fat-free mass28,40. In recent follow-up studies of patients with chronic
respiratory illness (obstructive lung diseases, tuberculosis sequelae, kyphoscoliosis,
other), an inverse relation between BMI and mortality has been identified36'39, but the
extent to which these findings reflect disease-related weight loss remains unresolved.
Among the never-smoking women studied here, we found evidence that weight
loss over a 17-year interval after baseline increased risk of fatal respiratory disease
regardless of baseline respiratory disease status (Table 2). Nevertheless, since exact time
of disease onset is unknown, we cannot determine whether the hazard due to weight loss
represents etiology, disease pathogenesis or both. If the hazard due to weight loss
primarily reflects advanced respiratory disease, then it is possible that the “protection”
conferred by high baseline BMI in the total population reflects a non-causal effect
whereby susceptible women in the high BMI category are more likely to be at an early,
non-fatal stage of the disease.
Therefore, we propose that the U-shaped relation between BMI and 17-29 year
risk of respiratory disease mortality among stable-weight women with no baseline history
of respiratory disease provides the most informative data on the independent role of BMI
in the etiology of fatal respiratory disease (Figure 2). This relation implicates obesity as a
risk factor, a finding that is consistent with known etiology among the obese by which
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excess abdominal adipose tissue impedes lung function (i.e. Pickwickian syndrome).
This relation, however, also implicates low body weight as a risk factor, though specific
mechanisms for this effect among apparently healthy, stable-weight women are less
certain. It is noteworthy that among never-smoking men of the AMS cohort a similar
increase in risk of fatal respiratory disease among the lean was observed29.

Therefore,

recent data linking lower estrogen levels to a number of respiratory events (bronchial
reactivity, asthma presentations, sleep-disordered breathing)41'44, raise the possibility that
lean cohort members with especially low endogenous estrogen levels (postmenopausal
women, men) experienced a greater risk of fatal respiratory disease. It has also been
hypothesized that lower levels of fat-free mass inhibit immuno-suppression28, suggesting
increased susceptibility to and worsened prognosis for infectious respiratory disease
among the very lean.
Limitations
Key variables (body weight, smoking history) for the analysis were obtained by
self-report. Nevertheless, in a sample of Adventist women14,45, the correlation between
self-report and direct measurement of body weight by a dietitian was high (R=0.94), and
of similar magnitude to correlations reported in other populations46. Misclassification of
self-reported smoking status has been evaluated in a number of populations47, and
misclassification rates between multiple self-reports given up to 16 years apart were low
(3-5% among ever-smokers, 1.3% in a large sample of never-smoking women). Among
the never-smoking women studied here who also reported smoking status 17 years after
baseline, 1.8% of the 1960 never-smokers reported ever-smoking in 1976. Also, Phillips
et al48 have reported an age-adjusted mortality ratio for lung cancer of 0.42 for neversmoking non-Hispanic white women of the 1960 AMS cohort we studied versus neversmoking non-Hispanic white women of the 1960 American Cancer Society cohort. These
data provide good evidence for no appreciable underreporting of smoking history among
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self-reported never-smokers of the Adventist cohort relative to self-reported neversmokers of a comparable population that was not exposed to a formal church proscription
on tobacco use.
Certain aspects of the study design may limit etiologic interpretation of the agedependency of the BMI-Mortality relation. The attenuated risk estimates for the older
women relative to the middle-aged women could be reflecting a survivor effect where
the proportion of women who were susceptible to mortality due to being in the extremes
of the BMI distribution would decrease over time. Also, an age-related increase in the
relative amount of fat-mass for a given BMI among older women28 may contribute to
variation in the BMI-Mortality relation by age stratum if the bias is differential.
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TABLE 1. Relation (Hazard Ratio and 95% Confidence Limits) between BMI and Age-Adjusted Mortality Risk from
Specific Diseases among Never-Smoking Middle-Aged (30- to 54-Year-Old) and Older (55- to 74'Year-OId) Women during
Three Study Periods of the 26-Year Follow-up*
Quintile I tit 1I-IV:
<21J kg/m2

Quintile V vs II-1V:
>27.4 kg/m2

Deaths per
Study Period

MiddZe-Aged Women
Yean 1-6
Cardiovascular
Cancer
Other

IJ (0.5.3.1)
1.1 (0.5.2.3)
2.6 (1.0.6J)

1.6 (0.7.3.7)
1.2 (0.6, 2.4)
2.2 (0.9.5.7)
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Yean 9-14
Cardiovascular
Cancer
Other

0.-9 (0J. 3 J)
1.1 (0.5. 2.2)
1.1 (0J. 3.9)

4.7 (2.1.10.4)
0.9 (0.4. 2.0)
1.8 (0.7,4.8)

28
50

Yean 15-26
Cardiovascular
Ischemic heart disease
Cerebrovascular disease
Hypertensive and ocher

1.4 (0.9,2.4)
1.0 (0.5.2.2)
1J(0J.4J)
2.5 (1.0.6.1)

2.6 (1.7.3.8)
2.6(1.6.43)
2.1 (0.9,5.1)
3.0 (IJ. 6.9)

127
71
26
30

Cancer
Hormone-related

1.0 (0.6.13)
1J (0.8.2.7)

1.5 (1.0. 2J)
1.7 (0.9.3.1)

145
63

Other

1J (0.8,2.5)
2.0 (0.8.4.8)
IJ (0.6.13)

1.8 (1.1.3.0)
0.7 (0.2.2J)
2.4 (IJ. 4J)

25
60

Respiratory
Nonrespiratory

49
26

20

85

Older Women
Yean 1-8
Cardiovascular
Cancer
Other

IJ (1.1,2.1)
1J (0.9. 2.4)
2.0 (1.1.3.8)

1.7 (IJ. 2.2)
1.9 (l J. 2.7)
1.5 (0.9.2.3)

250

Yean 9-14
Cardiovascular
Cancer
Other

1.0 (0.7, IJ)
1.0 (0.5.1.6)
l J (0.9.2.6)

1.4 (1.1, U)
1.7 (1.1. 2J)
IJ (1.0. 2.4)

377

Yean 15-26
Cardiovascular
Ischemic heart disease
Cerebrovascular disease
Hypertensive and ocher

0.9 (0.7.1.1)
0.9 (0.7.1.2)
0.8 (0.5.1.2)
0.9 (0.6,1.4)

1.2 (1.1.1.4)
1.2 (1.0.1.5)
1.1 (0.3.1 J)
IJ (1.1.2.0)

919
487

Cancer
Hormone-reiated

0.9 (0.6,1 J)
0.9 (0.4,1.9)

1.0 (0.7.1.4)
0.6 (0.3. IJ)

188
50

Other
Respiratory
Nonrespiratory

0.9 (0.6,1 J)
1.4 (0.8.2J)
0.7 (0.4.1.1)

1.0 (0.8.1.4)
0.6 (0J. 1.1)
IJ (0.9.1.9)

238

127
61

114
97

232
200

84
154

* Hazard ratio was determined from a Cox proportional hazard model with indicator variables for BMI Quintile* 1 and V (relative to Quintiles IMV) and a covanate
for logiage).

(Reproduced with permission from Singh PN, Lindsted KD. Body Mass and 26-year Risk of Mortality
from Specific Diseases among Women Who Never Smoked. Epidemiology 1998; 9:246-254)
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TABLE 2. Relation (Hazard Rado and 95% Confidence Limits) between Percent Weight Variability* and Age-Adjusted
Mortality Risk from Respiratory Disease,! Presented by Baseline Respiratory Disease (Bronchitis, Asthma, Tuberculosis)
Status among Never-Smoking Women (Ages 30-74 Years) Reporting Weight at Baseline in 1960 (Adventist Mortality Study)
and Again in 1976 (Adventist Health Study) and Surviving 17-29 Years after Baseline
Weight Loss
<90%

Stable Weight
90-110%

Weight Gain
>110%

Deaths

Baseline BMI below the mean!

3.6 (1.6,8.1)
3.4 (U4,8.3)

1.0
1.0

1.9 (0.5,7.4)
2.2 (0.6,8.4)

30
24

No respiratory disease at baseline
Total
Baseline BMI below the mean!

2.3 (1.3,4.3)
4.0 (1.8,8.9)

1.0

0.3 (0.04,2.4)
0.6 (0.1,4.4)

45

Respiratory disease at baseline

-fc.

1.0

27

• Percent weight variability ■ (body weight at year 17) X 100/body weight at baseline.
t Hazard ratio was determined from a Cox proportional haxard model with indicator variables for weight lou (<90% of baseline weight at year 17), weight gain (>110%
of baseline weight at year 17) relative to stable weight (90-110% of baseline weight at year 17) and a covariate for log(age).
t Mean DM1 for study population m 24.6 kg/m1.

(Reproduced with permission from Singh PN. Lindsted KD. Body Mass and 26-year Risk of Mortality
from Specific Diseases among Women Who Never Smoked. Epidemiology 1998; 9:246-254)

TABLE 3. Relation (Hazard Ratio and 95% Confidence
Limits) between Baseline BMI and Age-Adjusted Mortality
Risk from Respiratory Disease* among Never-Smoking
Women (Ages 30-74 Years) Reporting Weight at Baseline
in 1960 (Adventist Mortality Study) and Again in 1976
(Adventist Health Study) and Surviving 17-29 Years after
Baseline
Quintile I vs II—IV: Quintile V us II—IV:
<213 kgftn2
>27.1 kg/m2
Deaths
All women
No respixatory diseaset
No respixatoiy disease
4* no weight losst
No3 resptzacocT disease
+ no weight loss
4* no weight gain!

1.4(03,2.4)
10 (1.0,4.0)
15(1.0,6.7)

0.7(0.4,13)
1.4 (0.7,3.0)
16(1.0,63)

79
45
25

23(1.1,7.7)

17(1.1,7.1)

24

* Hazard ado was determined from a Cox proportional hazard model with
indicator variables for BMI Quintiles I and V (relative to Quintiles 1I-4V) and
a covariate for log(age).
t Bronchitis, asthma, or tuberculosis at baseline.
t Weight loss, <90% of baseline weight at year 17; weight gain, >110% baseline
weight at year 17.
• ?•

(Reproduced with perinission from Singh PN, Lindsted KD. Body Mass and 26-year Risk of Mortality
from Specific Diseases among Women Who Never Smoked. Epidemiology 1998; 9:246-254)
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FIGURE I. Relation between BMI and age-adjusted mortality risk from specific diseases among middle-aged (30-S4 years
at baseline) and older (55-74 years at baseline) women surviving 15-26 years after baseline report of body weight. An
age-adjusted hazard ratio and approximate simultaneous 95% confidence interval for BMI in kg per m1 (relative to a BMI of
24 kg per m2) were determined from Cox regression of an unrestricted quadratic spline function for BMI and are plotted on
logarithmic scale against BMI for each disease group. t5th to 95th percentile of age attained by middle-aged (30-54 years at
baseline) and older (55-74 years) women after 15-26 years of follow-up.

(Reproduced with permission from Singh PN, Lindsted KD. Body Mass and 26-year Risk of Mortality
from Specific Diseases among Women Who Never Smoked. Epidemiology 1998; 9:246-254)
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All women
10.0
5.0
Hazard
Ratio

P

2.0
1.0

0.5
0.2
0.1
18

22

26

30

Body Mau Indax (kg / m2)

Stable weight women *
with no history of respiratory illness *
10.0
5.0
2.0
Hazard

Ratio

1-°
0.5
0.2
0.1
18

22

26

30

Body Mass Max (kg / m2)

FIGURE 2. Relation between baseline BMI and age^ad'
justed mortality risk from respiratory disease among never*
smoking women (ages 30—74 years) reporting weight at
baseline in 1960 (Adventist Mortality Study) and again in
1976 (Adventist Health Study) and surviving 17—29 years
after baseline. An age*adjusted hazard ratio and approximate
simultaneous 95% confidence interval for BMI in kg per mz
(relative to a BMI of 24 kg per m2) were determined from
Cox regression of an unrestricted quadratic spline function
for BMI and are plotted on logarithmic scale against BMI for
each disease group, tStable'weight designates women who
remained within 90-110% of baseline body weight after 17
years of follow-up. tRespiratory illnesses include bronchitis,
asthma, and tuberculosis. •>;
•i i* %
(Reproduced with permission from Singh PN, Lindsted KD. Body Mass and 26-year Risk of Mortality
from Specific Diseases among Women Who Never Smoked. Epidemiology 1998; 9:246-254)
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Appendix
We used spline regression methods described in detail by
Greenland.24 Briefly, the indicator variables for BM1 in each
Cox regression model were replaced with terms for an unre
stricted quadratic spline function of die continuous BMI vari
able that fits a quadratic function within n sequential ranges of
BMI: .
.

log[K(t)/Vt)]|BMI, p • Ji + 2 71 *? + Z fy1!
1
where s, * B log(BMI) + ji flog(BMJ)]3 and for: > 1, sf « 0
if BMI ^ lower boundary of the range, and s, * log(BMI) —
log(lower boundary of die range) if BMI > lower boundary of
die range; for i > 1, the regression coefficient y, is die incre
mental change in the quadratic term for adjacent ranges; d; pt
is the product of the /th confounder covariate, ft, and its
respective regression coefficient, 6t
Using this model, a hazard ratio was computed as, exp[Z‘{X
— JTt)], where Z is die parameter vector (£, yu.. ., a), X is the
covariate vector DogfBMI), logfBMI)2, *j,.... *3 for a given
BMI, and Xr is the covariate vector for a referent BMI value.
Smooth curves were then constructed by plotting the hazard
ratio against BMI. Approximate simultaneous 95% confidence
limits around selected regions of this curve were computed by:
: exp(Z • (AT — X,) £ A vj
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where A is the square root of the 97.5th percentile of the x2
distribution at n + 1 degrees of freedom (n+1 ■* number of
parameters in Z), and tfc, die variance of £ - X* is given by:

1'Cr

cr-xrCtf-*)

Q-S

where £ is the estimated covariance matrix for Z.
For each spline regression model, we performed influence
analysis by generating index plots of the estimated delta-beta
value49 for each of the parameters in Z, such that for the jth
observation, Y, contains die delta-beta value for each of die
parameters in Z. To assess the overall fit of the spline function,
we determined the estimated change in die —2 log L(Z) after
the omission of the jth observation,10 where the change or
“likelihood displacement” is given by:

U

TjdVi-

% =
.2
o

For one of die models (Figure 1, middle-aged women, hyper
tensive + other cardiovascular), an influential outlier was
identified by these methods and excluded. For all models,
exclusion of subjects at die extremes of the BMI distribudon
(<15 kg per m2, >35 kg per m2) did not change the overall
shape of the curves. The delta-beta procedure was used for
influence analysis of models with log(BMI) as the only expo
sure variable for the index.
Model Specification for Figures 1 and 2
For each model, we used an unrestricted quadratic spline
function of .the continuous variable with two “knots” that
corresponded to the quintile categories (I, II-IV, V) used in
the indicator variable regression (n * 3). Hazard ratios plotted
in Figures 1 and 2 were determined by using the median of
Quintiles II-IV (24 kg per m2) as a referent, Xr This allowed
for comparability between these estimates and the hazard ratios
computed from the indicator regression in Table 1 and 3,
where Quintiles II-IV are used as a referent.
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CHAPTER 4
STUDY II: BODY WEIGHT AND MORTALITY AMONG ADULTS WHO NEVER
SMOKED

Preface to the Manuscript

Study II continues the investigation of body weight and mortality among neversmoking adults of the California Seventh-day Adventist population. The Adventist
Mortality Study, described in Study I, enrolled a study population that represents a
sample of the California Seventh-day Adventist population that was taken in 1960. In
Study II, I have examined the relation between body mass index and mortality among
adults of the Adventist Health Study, a population that represents a sample of the
California Seventh-day Adventist population that was taken in 1976. Since the study
base has been sampled twice (in 1960 and in 1976), about half of the older cohort
members of the Adventist Health Study were also cohort members of the earlier
Adventist Mortality Study. The two measures of body weight among these adults
therefore allowed for an accounting of weight variability when considering the relation
between body mass index and mortality among adults in Study II.
In Chapter 2,1 have presented a set of recommendations for the control of
confounding when evaluating the BMI-Mortality relation. These recommendations have
been applied to Study II and resulted in the use of the following methods: 1) exclusion of
current and former smokers from the analysis, 2) an early mortality exclusion with an « of
up to 17 years, and 3) subgroup analyses that excluded subjects with chronic disease
history (heart disease, stroke, cancer) and large changes in body weight.
Study II is presented in the form of a formatted manuscript that is in press at the
American Journal ofEpidemiology (Appendix, “Copyright Permission”).
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Body Weight and Mortality Among Adults Who Never Smoked
(reproduced with permission from Singh PN, Lindsted KD, Fraser GE. Body Weight and
Mortality among Adults Who Never Smoked. Am J Epidemiol 1999; (in press))
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Abstract
In a 12-year prospective study, the authors examined the relation between body
mass index (BMI) and mortality among the 20,346 middle-aged (25-54 years) and older
(55-84 years) non-Hispanic white cohort members of the Adventist Health Study
(California, 1976-1988) who had never smoked cigarettes and had no history of coronary
heart disease, cancer, or stroke. In analyses that accounted for putative indicators of pre
existing illness (weight change relative to 17 years before baseline, death during the first
6 years of follow-up), the authors found a direct positive relation between BMI and all
cause mortality among middle-aged men, older men, and middle-aged women, and a J shaped relation among older women. Further study of the older women, 96% of whom
were post-menopausal, revealed that low BMI was a risk factor only among those who
had not undergone post-menopausal hormone replacement therapy.

These findings

implicate body weights that exceed the upper limit of the currently recommended range
for US adults (25 kg/m2) as a risk factor among middle-aged and older adults, and body
weights marginal to or below the lower limit of the recommended range (19 kg/m2) as a
risk factor only among those older women who had not undergone post-menopausal
hormone replacement therapy.
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Introduction
A relation between body weight and mortality has been documented in numerous
prospective studies that have clearly established obesity as a risk factor for major fatal
disease among adults1,2. The possibility that very low body weight maintained among
healthy adults is a risk factor for fatal disease remains an important clinical and public
health issue, particularly after the recent downward revision of the lower limit of US
weight guidelines for healthy adults3,4 from a body mass index (weight divided by the
square of height) of 21 kg/m2 to a body mass index of 19 kg/m2.
The higher mortality risk among adults in the lowest weight-for-height category
observed in numerous populations over the past 30 years, has in the past decade been
attributed to confounding by smoking and pre-existing illness5. However, in recent
prospective studies of apparently healthy non- or never- smokers, the mortality risk
among those in the lowest body mass index (BMI) category was equivocal or protective
in some 6-10 , but not all

11-16

populations. It is noteworthy that the relation between BMI

and mortality reported for apparently healthy never- or non- smokers of these
populations616 does seem to vary by age and gender. Among women8,9,11'16, increased
mortality risk among those with the lowest BMI was found among older women (baseline
BMI given at or after the sixth decade)11'16, but risk was either equivocal or protective
among middle-aged women (baseline BMI given at the third, fourth, or fifth
decade) 8,9,15,16 . In contrast, no significant elevation in mortality risk for the lowest BMI
category was observed among middle-aged or older men 6,7,9,10,11,13,16
These recent findings raise the possibility that an age-related etiology may be
influencing the risk due to low BMI among women, but not men. The menopause is a
particularly noteworthy age-related factor given that ovarian senescence or ovariectomy
would likely produce an especially low serum estradiol level among women of low
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BMI17'19, whose lower adipose tissue mass would further limit the synthesis of estrones by
adipose tissue-derived aromatases19. Thus, a pathology related to hormone levels,
particularly estrogen levels, may explain some of the difference in the mortality risk due
to very low body weight between pre-menopausal women and post-menopausal women.
Such variation in the BMI-Mortality relation by age and gender can be well-studied in
age-stratified groups of women and men drawn from a population that is homogeneous
with respect to other predictors of fatal disease.
In the present cohort study, we have examined the variation in the relation
between BMI and the 12-year risk of mortality by age (age 25-54 years, age 55-84 years)
and gender among the 20,346 never-smoking, non-Hispanic white cohort members of the
Adventist Health Study (AHS) with no history of coronary heart disease, stroke, or cancer
at baseline. About half of the older cohort members gave anthropometric data 17 years
before baseline at enrollment into the Adventist Mortality Study (AMS)1015, and therefore
their records provided an opportunity to examine both the long-term (17-29 year) risk due
to BMI, and the long-term risk due to BMI among adults whose baseline body weight
remained stable relative to 17 years prior.
The Adventist population is characterized by very little smoking or alcohol use
and a large proportion of members adhere to a lacto-ovo vegetarian diet20. Among the 2584 year-old, never-smoking AHS cohort members we studied, the low prevalence of other
traditional risk factors for chronic disease (alcohol use, saturated fat intake) provided a
unique opportunity to study the effect of BMI on survival through the ninth decade.
Methods
The Adventist Health Study Cohort 0976-1988)
The Adventist Health Study (AHS) is a prospective investigation of 34,198 nonHispanic white adults who were identified during a census that was taken between 1974
and 1976 to identify all Seventh-day Adventists residing in the state of California. The
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details of this census and the mailed census questionnaire that was used have been
previously described20'21. In 1976, a lifestyle questionnaire was sent to 59,081
respondents to the census questionnaire who were 25 years or older. There was a 75.1%
response rate to the lifestyle questionnaire among non-Hispanic whites. This respondent
group (n=34,198) became the study population for the present cohort study.
During 12 years of follow-up (1976-1988), deaths in this study population were
ascertained by record linkage with the California Death Certificate File, record linkage
with the National Death Index, and use of church records to obtain sufficient information
on a potential decedent that would enable the AHS to order a death certificate. The
validity of the record linkage procedure has been evaluated and it was found that 3-4% of
the deaths in the study population were not ascertained by the record linkage procedure.
In the total study population, there was not a sufficient number of current
smokers, former smokers, subjects of age 85 years or older, or subjects with previously
diagnosed coronary heart disease, stroke, or cancer to allow for separate analyses of each
group. To account for possible differences in the BMI-mortality relation for these
groups5,22, we restricted the analysis to the 20,346 (13,281 women, 7,065 men) neversmoking, 25-to-84-year-old cohort members who provided complete anthropometric data
at baseline and had no history of coronary heart disease, cancer, or stroke.
Adventist Health Study 0976-1988") Cohort Members who were also
enrolled in the Adventist Mortality Study 0960-1985)
From 1959-1960, the Adventist Mortality Study investigators23-24 , under a
cooperative agreement with the American Cancer Society, administered the 1960
American Cancer Society questionnaire to a study population consisting of California
Seventh-day Adventists identified during a 1958 census that was taken to identify church
members residing in California23. This study population underwent 26 years of mortality
surveillance by the Adventist Mortality Study (AMS)10’15.
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members studied in this report, 47% represent a subcohort who were enrolled in the AMS
in 1960, at ages 38 to 67 years. Therefore, we have used the AMS records for this
subcohort to examine the relation between BMI given 17 years before baseline and
mortality risk, where the 12-year follow-up gives the 17-29 year risk due to BMI. To
control for the effects of weight variability, we also present analyses restricted to those
subcohort members whose baseline body weight at enrollment into the AHS was within
10% of the body weight reported 17 years before baseline at enrollment into the AMS
(90% < 1976 body weight x 100 / 1960 body weight < 110%).
Baseline Questionnaire
AHS cohort members completed a mailed lifestyle questionnaire in 1976 that
included items on demographics, dietary intake, anthropometric data, physical activity
level, psychosocial factors, medication use, and diagnosed disease history. BMI was
determined from items on current weight (in pounds) and height (to the nearest inch) in
indoor clothing and without shoes. The validity of the anthropometric data was tested in
a random sample of 118 cohort members25 in which the correlation between body weight
given on the baseline questionnaire and body weight measured by a dietitian (up to one
year after baseline) was 0.94 for women and 0.96 for men. The correlation between body
height given on the baseline questionnaire and body height measured by a dietitian (up to
one year after baseline) was 0.94 for women and 0.96 for men.
The dietary information section of the questionnaire included 55 semi-quantitative
food frequency items. A total meat index was determined from the response to items on
intake of all meats and specific meats and was used to classify subjects as vegetarian
(meat intake < 1 x /week) and non-vegetarian (meat intake > 1 x /week). Data from a
previously described substudy26’27 of a random sample of 147 cohort members who gave
five 24-hour recalls to dietitians was used to test the validity of the food frequency items
and to develop nutrient indices28,29. Correlation coefficients between questionnaire data
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and to develop nutrient indices28,29. Correlation coefficients between questionnaire data
and corresponding 24-hour recall measures were 0.44 for saturated fat intake and 0.83 for
total meat intake.
A physical activity index is calculated from the response to items on vigorous
leisure-time or occupational activities and classifies subjects into a “high” category for
frequent (15 minutes or more per session, 3 times or more per week) participation in
vigorous activity, a “moderate” category for less frequent (< 15 minutes per session, < 3
times per week) participation in vigorous activity, and a “none/low” category for a “rarely
or never” response to vigorous activity items. This index is a significant predictor of fatal
coronary events30, breast cancers31, and all-cause mortality32 in the cohort. Also, survey
measures of vigorous activity are positively correlated with maximal treadmill time
among non-Hispanic white Adventists33.
Among women, menopausal status was determined from the response to items on
the regularity of menses, cessation of menses, and reasons for cessation of menses
(natural, surgical). Using these data, 29% of the middle-aged (25-54 years) women and
96% of the older women were classified as post-menopausal. Use of post-menopausal
hormone replacement therapy was determined from items on the use (current, past, never)
of ‘hormone medicines for menopause (premarin or others)’ and duration of use (<1 to >
10 years) among current and former users. These items were used to classify women as
non-users (never used or former user for less than a year), users for up to 5 years (current
user up to 5 years or former user for 1-5 years), and users for greater than 5 years (current
or former).
Statistical Analysis
The major study endpoint was all-cause mortality (ICD-9: 0-999). Diseasespecific endpoints included mortality from cardiovascular disease (ICD-9: 390-398, 400404, 410-414, 420-429, 430-438, 440-458), cancer (ICD-9: 140-239), respiratory illness
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(460-466, 473-494,496,510-519) and all other causes. In certain analyses, specific
underlying causes of cardiovascular [ischemic heart disease (ICD-9: 410-414),
cerebrovascular disease (ICD-9: 430-438), hypertensive and other disease (ICD-9:400404, 420-429,440-458)] and cancer [hormone-related (ICD-9): 174, 179,182,183] deaths
were also considered. BMI was categorized into quintiles for the analysis of women (I,
13.3- 20.6 kg/m2; II, 20.6-22.4 kg/m2; III, 22.5- 24.2 kg/m2; IV, 24.3-27.4 kg/m2; V,
27.5-65.6 kg/m2) and men (1,13.5- 22.3 kg/m2; II, 22.3-23.7 kg/m2; III, 23.8-25.3
kg/m2; IV, 25.4-27.3 kg/m2; V, 27.4-51.7 kg/m2).
Hazard ratios for quintile-based categories of BMI were computed relative to the
middle quintile (III )or quintiles (II-IV) from proportional hazard regression with time on
study (in months) as the time variable. Quintiles II-IV were used as the referent in
analyses in which the mortality rates were low and the hazard ratios for quintiles II,III,
and IV were similar. All models included a continuous variable for age at baseline, and
in larger models additional covariates were tested.
The model assumption was evaluated by adding product terms for BMI quintile '
time on study and by examining age-adjusted (by direct standardization)34 log-log plots of
the product limit estimator of the survival function for BMI categories. We also
evaluated possible dependency on follow-up time by dividing the 12-year follow-up
period into two smaller study periods (years 1-6, 7-12) of approximately equal personyears and determining the BMI-Mortality relation for each study period.
Linear and non-linear trend analysis was used to formally test for a direct versus J
- or U - shaped BMI-Mortality relation. The methods used for trend analysis have been
described in detail by Greenland35 and our application of these to the BMI-Mortality
relation described in previous reports10,15. To test for non-linear trend, the indicator
variables for BMI in each proportional hazard regression model were replaced with terms
for an unrestricted quadratic spline function that fits a quadratic function within three
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BMI quintile-based categories (I, II-IV, V):
log h (t)/ho (t) =
terms

log (BMI)

+

log (BMI)2

+

2 quadratic spline

The significance level from a log likelihood ratio test of the quadratic terms (log (BMI)2 + 2
quadratic spline terms) in this model is then reported as non-linear trend. When non-linear
trend was not detected by these methods, we tested for linear trend in a model with log
(BMI) as the only variable for BMI.
RESULTS
During 231,173 person-years of follow-up, 2,364 deaths were identified in the
analytic population, and were classified by underlying cause into 1,243 deaths from
cardiovascular disease (53% of all deaths), 448 deaths from cancer (19% of all deaths),
141 deaths from respiratory illness (6% of all deaths), and 532 deaths from all other
causes (22% of all deaths). Selected baseline characteristics of the study population are
reported by age, gender, and BMI category in Table 1. Among adults in the low and
middle BMI quintiles, a vegetarian diet pattern and high physical activity were more
prevalent, while diabetes, and high blood pressure were less prevalent.
The findings from models with a product term for BMI (time on study and from
age-adjusted hazard plots for BMI indicated that the hazard for BMI varied with follow
up time among middle-aged women, middle-aged men, and older men. Therefore, in
table 2 we have presented the age-adjusted hazard ratios relating BMI (in quintile
categories) to all-cause mortality risk that were determined from separate models by age
(middle-aged, 25-54 years; older, 55-84 years), gender, and study period (years 1-6, years
7-12). Results for middle-aged and older adults are summarized separately as follows,
and additional data for older adults is given in Tables 3-6.
Middle-aged Adults
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During years 1-6 (Table 2), a J shaped relation between baseline BMI and risk of
all-cause mortality was evident among women and men. These non-linear trends reduced
to positive linear trends during years 7-12 (Table 2), that were significant among women
((3 for linear term= 1.7, p=0.001), and marginal among men ( p for linear term= 1.4,
p=0.12). In models for cardiovascular disease mortality risk, trends were U-shaped for
women (non-linear trend, p = 0.001) and linear for men ( p for linear term= 5.1, p=0.06)
during years 1-6, and linear for both women ( p for linear term= 3.5, p =0.0003) and men
( p for linear term= 3.8, p=0.01) during years 7-12.
Older Adults
Among older women, we found an approximately U -shaped relation between
baseline BMI and mortality risk during years 1-6, that persisted as a J-shaped relation
during years 7-12 (table 2). Among older men, we found a J-shaped relation between
baseline BMI and mortality risk that only became evident after 7-12 years of follow-up
(table 2). We explored whether these associations with baseline BMI presented in table 2
could also be found when relating BMI given 17 years before baseline to the subsequent
17-29 year mortality risk. Among older women, we found a similar J -shaped relation
(table 3). Among older men, however, we found a direct positive relation between BMI
and the 17-29 year mortality risk (table 3).
Our findings among older men indicating a J-shaped relation in the ‘baseline
BMP analysis (table 2, years 7-12) but a direct positive relation in the ‘BMI 17 years
before baseline’ analysis (table 3) raise the possibility that the risk due to low baseline
BMI may be confounded by the change in body weight that occurred between 17 years
before baseline and baseline. We tested this hypothesis in an analysis (data not shown in
table 3) of those older men who reported body weight at 17 years before baseline and
baseline (49% of the older men in the parent cohort). Among these men, we found a
positive correlation (R= 0.42, p =0.0001) between weight change (body weight at
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baseline-body weight 17 years before baseline) and baseline BMI and a U-shaped
relation (p non linear trend =0.03) between weight change and 7-12 year mortality risk,
and therefore concluded that weight change represents a potential confounder of the risk
due to baseline BMI. In further analysis of these men, we then found that the J-shaped
relation between baseline BMI and 7-12 year mortality risk reduced to a direct positive
relation (HR [95% Cl] for BMI quintiles I, II,III,IV, V: 0.8 [0.5, 1.4], 1.2 [0.7, 2.0], 1.0,
1.1 [0.6, 1.8],1.6 [1.0, 2.7]; p linear trend =0.05) after restriction of the analysis to stable
weight men (body weight given at baseline within 10% of body weight given at 17 years
before baseline). Thus,, after accounting for the confounding effects of non-stable
weight, we found evidence for a direct positive relation between baseline BMI and 7-12
year risk of mortality among older men.
In Table 4, we present findings that relate baseline BMI to disease-specific
mortality risk. These data indicate that the U-shaped BMI-mortality relation among
older women was primarily due to a higher risk of cardiovascular disease, respiratory
disease, and other disease (unrelated to cancer) among women of the lowest BMI (13.320.6 kg/m2), and a higher risk in all major disease categories (cardiovascular, cancer,
respiratory, other) among women of the highest BMI (27.5-65.6 kg/m2). Among older
men, we found that the only evidence of disease-specific risk for those of the lowest BMI
(13.5-22.3 kg/m2), was for respiratory disease, while for those of the highest BMI (27.451.7 kg/m2 ), an increased risk was evident in all major disease categories. In analyses
relating BMI at 17 years before baseline to mortality risk, we found similar diseasespecific patterns among women, but among men, found no disease-specific risk factor
associations for the lowest BMI.
We tested for possible complex relations by considering the impact of other
variables on the BMI-Mortality relation. In larger models, we determined the hazard
ratios for BMI by levels of each of the following variables: hormone replacement therapy
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among older women (non-user, user for up to 5 years, user for > 5 years), age at
menopause among older women (>50 years, < 50 years), meat intake (< 1 x per week, > 1
x per week), saturated fat intake (< 22 g/d, 22-27 g/d, > 27 g/d), physical activity
(moderate-to-high, none-to-low), and education (> 12 years, <12 years).

Among older

men, we found no important variation in the BMI-Mortality relation across levels of the
relevant variables. Among older women, the BMI-Mortality relation did vary by use of
hormone replacement therapy, and hazard ratios for BMI by hormone replacement
therapy use are presented in Figure 1 and Table 5.
Figure 1 shows that among older women, a baseline BMI that ranged from 13.420.6 kg/m2 was a risk factor for all-cause mortality only among non-users of hormone
replacement therapy. These findings for baseline BMI were not altered by exclusion of
the first six years of follow-up {Hormone Use Category, HR [95% Cl] for BMI quintiles
I, II-IV, V: Non-user, 1.9 [1.4,2.6], 1.3 [1.0, 1.8], 1.8 [1.3, 2.4]; User for up to 5 years,
1.0 [0.6, 1.8], 1.0, 2.0 [1.3, 3.1]; User for greater than 5 years, 1.1[0.7, 1.7], 1.3 [0.9,
1.7], 1.6 [1.0, 2.4]).

The findings for BMI at 17 years before baseline in Figure 1,

provide the additional insight that risk due to the apparent long term (17-year)
maintenance of low BMI was only modified by long term (> 5 years) use of hormone
replacement therapy.
Disease-specific risk estimates for BMI by hormone replacement therapy use in
Tables 6-7, indicate that excess risk among non-users with low BMI was primarily due to
fatal cardiovascular and respiratory diseases. For the cardiovascular disease mortality
endpoints, however, modification of the risk due to low BMI by hormone use was only
evident among stable weight women (Table 6), suggesting that weight change may have
obscured this relation in the parent cohort.
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Multivariate Models
The age-adjusted analysis described above was also conducted after inclusion of
other covariates (education, meat intake, physical activity, time since last physician visit,
alcohol use, saturated fat intake, age at menopause, disease history) into the models. The
only noteworthy change in the BMI or BMI by hormone replacement therapy use risk
estimates after multivariate adjustment was an attenuation in the risk for BMI Quintile V
after inclusion of covariates for diabetes and hypertension.
DISCUSSION
Our results provide the relation between BMI and 12-year risk of mortality from a
cohort of non-Hispanic white middle-aged (age 25-to-54 years) and older (age 55-to-84
years) adults who never smoked. At baseline, this cohort also exhibited low intake levels
of alcohol (8%, > 0 x / week), meat (43%, > 1 x / week), and saturated fat (25 ± 6
g/day). After accounting for several possible indicators of pre-existing illness (chronic
disease history, non-stable weight among older adults, death during the early follow-up),
we found a direct positive relation between BMI and all-cause mortality among middleaged men, older men, and middle-aged women, and a non-linear, J-shaped relation among
older women. Further study of the older women revealed that among those of the lowest
baseline BMI (13.4-20.6 kg/m2), increased mortality risk was only found among those
who had not used hormone replacement therapy.
The current findings from the Adventist Health Study cohort add to the data from
numerous studies that relate a BMI of greater than 27 kg/m2 to a higher risk of
mortality1,36, particularly from cardiovascular disease and cancer. The unique distribution
of risk factors in the AHS cohort does, however, provide the additional insight that
obesity remained an important risk factor for fatal disease even among adults exhibiting a
low (alcohol use, saturated fat intake) or zero (cigarette smoking) prevalence of other
traditional risk factors for chronic disease.
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The 12-year findings from never-smoking Adventist Health Study (California,
1976-1988) cohort members reported here is in concordance with the 26-year findings
from never-smoking Adventist Mortality Study (California, 1960-1985) cohort
members10,15 that also indicated a direct positive relation between BMI and mortality in
all age and gender subgroups except older women, among whom a U-shaped relation
became evident after the fifth decade. This study adds to the concordant findings from
both cohorts the possibility of a multifactorial pathology among older women that
involves low body weight and hormone replacement therapy.
Findings from a number of adult cohorts provide evidence that increased mortality
risk observed among those of low BMI (usually less than 21 kg/m2) is at least partly
attributable to the high prevalence of negative prognostic factors among the lean
(cigarette smoking5,7 8,9,13,37 38, alcohol use38, poverty39) and/or the likelihood that a
proportion of the baseline lean were lean due to disease-related weight loss40,41.
Nevertheless, in recent studies of apparently healthy non- or never- smokers, an increased
risk due to low BMI remained particularly evident among older women (BMI given at or
after the sixth decade)11'16.
In the cohort we studied, the substantially higher baseline prevalence of natural or
surgical cessation of menses among older women (96% post-menopausal) relative to
middle-aged women (29% post-menopausal) provides a plausible explanation for the
increased risk due to low BMI that was evident at older age (Tables 2-3), but not middleage (Table 2). Since the adipose tissue becomes the primary endogenous source of
estrogens only after menopause, a reasonable hypothesis would be that increased risk
observed among post-menopausal women of low BMI is mediated by their lower
adipose-derived estrogen levels.
We found support for this hypothesis in our findings indicating that among older
women with a BMI of 13.4-20.6 kg/m2, those who had undergone hormone replacement
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seem to avoid an increased risk relative to their heavier peers (Figure 1). It is important
to note that the major form of postmenopausal hormone replacement therapy that was
prescribed at or before baseline (in 1976) was unopposed estrogens that, during the
1970s, were commonly administered at high doses (> 1.25 mg/day), at non-cyclic
intervals, and over long periods of time. As might be expected, the baseline hormone use
data on the women we studied, do relate hormone use to higher incident breast cancer
risk42 and lower incident coronary heart disease risk43 during the follow-up. Thus,
estrogen preparations administered at high dosage levels (relative to current standards)
seem to have prolonged survival among the older women of BMI 13.4-20.6 kg/m2 that we
studied.
Differences in disease-specific mortality risk between non-users and users in the
lowest BMI range provide further insight into a possible “treatment effect”. The higher
risk of fatal cardiovascular diseases for the non-users of low BMI is consistent with
known mechanisms by which lower estrogen levels would increase risk of vascular
disease (enhanced atheromatous plaque formation, decreased vascular flow, increased
blood pressure, increased low density lipoprotein levels)44. The more than four-fold
elevation in risk of fatal respiratory disease among non-users of low BMI (Table 7)
implicates low estrogen levels in the pathogenesis of this disease, an effect that might
also explain the higher risk among lean older men. This association may have some
plausibility given data from a few recent clinical studies indicating that increased
estrogen levels achieved either by supplementation, pregnancy, or phase of the menstrual
cycle significantly reduced either bronchial reactivity45,46, clinical severity of asthma46,47
or sleep disordered breathing48. Also, animal models support protective mechanisms for
natural or synthetic estrogens that include increased cyclic AMP release in respiratory
tract smooth muscle50, increased gas exchange surface area51, and inhibition of
peroxidative membrane damage52.
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Despite the overall survival advantage for hormone replacement among older
women of BMI 13.4-20.6 kg/m2, it is noteworthy that older women of low or mid-range
BMI who had not undergone this therapy experienced a two-fold lower risk of fatal
cancers of the breast, uterus, and ovary relative to all other profiles (Table 7), each of
which included either high BMI or hormone use. This finding is consistent with the
accumulated evidence that higher total estrogen levels (endogenous or exogenous)
contribute to the risk of these cancers53,54.
Barrett-Connor56 and others57 have proposed that the lower morbidity and
mortality rates found among users of estrogen replacement therapy in observational
studies may reflect the higher prevalence of positive prognostic factors (better access to
medical care, higher education level, higher physical activity, higher HDL cholesterol,
lower alcohol intake) among users relative to non-users. Recent findings from a large
randomized clinical trial indicating no decrease in short term (4 years follow-up)mortality
risk for post-menopausal hormone replacement among women with coronary heart
disease58 have also been cited as evidence against a causal interpretation of the decrease
in risk that has been associated with this therapy in observational studies59. In the
Appendix, we therefore present the distribution of a number of possible prognostic
factors by category of BMI by hormone use in order to evaluate whether the users we
studied were “healthier”57. These data indicate that a modestly higher proportion of users
had college level education and more frequent physician visits as compared to non-users.
As noted above, however, multivariate adjustment for these variables did not appreciably
alter the risk estimates for BMI by hormone use. Additionally, the protective effect of
hormone use among the leanest older women, as shown in Figure 1, remained even after
restriction of the analysis to women who had been seen by a physician during the two
years prior to baseline, or in separate analyses of women with more than 12 years of
education and 12 or less years of education. Thus, using the available baseline data we
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found no evidence that the protective effect of hormone replacement therapy among the
lean older women we studied was attributable to positive prognostic factors other than the
therapy itself. Since our findings are from observation, however, we still cannot exclude
the possibility that confounding due to unmeasured factors remains.
A notable limitation of this study is that the “low risk” distribution of lifestyle
factors in the study population limits the direct application of the findings to the general
US population. It should be noted, however, that since the purpose of our study was to
identify the independent effect of BMI on mortality, the use of a subgroup that is at “low
risk” due to a low prevalence of potential confounders may better achieve this purpose as
long as sufficient variation in BMI remains in the subgroup. In the cohort we studied,
we found the mean BMI of the middle-aged women (23.8 kg/m2), older women (24.7
kg/m2), middle-aged men (24.8 kg/m2), and older men (24.7 kg/m2) to be quite similar to
the mean BMI for the corresponding age-gender subgroups of cohorts that are more
representative of the US population 13,16,60,61
Our findings from never smoking 25-84 year-old adults indicate that those whose
BMI exceeded the upper limit (25 kg/m2) currently recommended for US adults4,62
experienced increased mortality risk through the ninth decade. Among those whose BMI
was marginal to or below the lower limit (19 kg/m2) of the currently recommended
range4, we found increased risk only among those older women who had not used
hormone replacement therapy. Our findings raise the possibility that lean older women
can experience an increased mortality risk due to their lower levels of adipose tissuederived estrogens.
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Table!,
Selected baseline characteristics of the 20,354 never-smoking Adventist Health Study cohort members are given by age, gender, and body
mass index (BMI).
Women
BMI Quintile
I
13.3-20.6 kg/m1

Range (25-75* percentile)
of Body Weights (lbs)
age 25-54 yean 110-125
age 55-84 years I0S-I20

BMI Quintile
ll-IV

BMI Quintile
V

MJzllA kg/m*

Men
BMI Quintile
I
13.5-22.3 kg/m1

BMI Quintile
ll-IV

BMI Quintile
V

22.4-27.3 Ite/m*

27.4-31.7 ke/m1

140-155
130-150

164-185
160-180

195-228
186-215

127-145
127-147

170-200
160-185

II
4

9

10

15

4

5

7

15
9

61
71

52
57

39
42

73
73

52
57

38
43

26 (5)
20 (5)

25(5)
21(5)

26(6)
22 (5)

29(6)
25(5)

3tr(6)
26.(5)

31(6)
27(6)

85
55

77

69

56

47

92
63

89
68

84
65

35
42

34
41

28

48
53

43

35

34

49

43

I
5

2

7
12

I

I

3

5

5

6

9

4
23

9

34

50

3
10

9

31

20

27
34

92
87

91
89

92
91

80
79

79
80

85
84

14
39

23

23

46

38

41(8)

41(8)

47(7)

47(7)

Alcohol U$c(%)*
age 25-54 yean 12
age 55-84 yean 2
Vegelarian(*/*)t
age 25-54 yean
age 55-84 yean
Mean Saturated Fat Intake (g/day)
age 25-54 yean
age 55-84 yean
> 12 yean of Education (*/•)
age 25-54 yean
age 55-84 yean
High Physical Activity Level (V*)|
age 25-54 yean
age 55-84 yean

u>

Diabetes (%)

age 25-54 yean
age 55-84 yean
High Blood Pressure (%)
age 25-54 yean
age 55-84 yean
Physician Visit within the
past two yean
age 25-54 yean
age 55-84 yean
Hormone Replacement Therapy
User (•/•)$
age 25-54 years
age 55-84 years
Mean Age at Menopause
among Postmenopausal
Women (years)

age 25-54 yean 40 (8)
age 55-84 yean 47 (7)

!

Table 2.
Among never-smoking middle-aged (age 2S-S4 years) and older (age 55-84 years) adults of the Adventist Health Study cohort, age-adjusted
hazard ratios [95% Cl] relating quintiles of baseline body mass index (BMI) to all-cause mortality risk are presented by age, gender, and study period.
Non-

Hazard Ratio (95% Cl| by DMI Quintile*#

-4

Middle-aged Adulls
Women
Years 1 lo 6
Years 7 to 12
Men
Years 1 to 6
Years 7 to 12
Older Adults
Women
Years 1 to 6
Years 7 to 12
Men
Years 1 to 6
Years 7 to 12

l
1.2 [06,2.6]
0.6 (0.2, 1.2]
2.0 (0.9,4.2]
0.9 [0.3, 1.9]

iii

IV

V

Linear Linear
Dcaihi Trcndt Trendt_______

(
(

1.0
1.0

V

2.0(1.0,37]

49

l1

1.9(1.2,30]

94

(
(

1.0
1.0

)'
I1

1.6 (0.7,36]

37

1.3 (0.1,2 6]

63

l.0«
I.01

1.1 (0.9, 1.3]

1.6 (1.2,2.1]

344

1.1 [0.9, 1.3)

1.3 [1.2, I.S)

942

1.0*
1.0*

1.0 (0.6, 1.4]

1.2 [0.8, 1.8)

231

1.2 (0.9, 1.7]

1.8 (1.3,2.3)

382

II

1.6 [1.2,2.1]

1.4(1.1, 1.9]

1.3(1.1, 1.6]

0.9 (0.7, 1.2]

0.9 [0.6, 1.4]

1.2 [O S, 1.7)

1.3 [1.0, 1.9]

1.3(1.1,20]

0.007
0.001

0.0001
0.0000 i

0.009

Hauril Ratio was determined front proportional hazard regression with indicator variables for DMI quintiles and a continuous covariale for age.

t

Linear trend was determined from proportional hazard regression a variable for log(DMI in kg/m?) and a continuous covariale for age. The significance level of the regression coefficient for log(BMI) is
reported as linear trend. A

I

Non-linear trend was determined from Cos regreuion of an unrestricted quadratic spline model (33). The significance level from a log likelihood ratio lest of the quadratic terms of this model is reported as
non-linear bend. A

1

indicates non-significant trend statistic or that linear trend was not evaluated since significant non-linear trend was identified.

Referent Category

indicates a non-significant trend statistic.

Table 3.
Among never-smoking older adults (age 55-84 years) of the Adventist Health Study (California, 1976-1988) cohort who gave
anthropometric data 17 years before baseline, age-adjusted hazard ratios [95% Cl] relating BMI 17 years before baseline to subsequent 17-29 year all
cause mortality risk are presented by gender and weight variability status (‘stable weight' indicates that baseline body weight was within 10% of body
weight 17 years before baseline).
II

ill

JV

V

NonLinear Linear
Deaths Trendt Trendl

l.2(0.9,l.6]
1.3 [0.9, 1.8]

10(0.7,1.2]
0.9 [0.7, 1.3]

l.o1
1.0*

1.2 [0.9, 1.4]
1.2 [0.9, 1.6]

1.7 [1.4,2.1]
1.7 [1.3.2.2]

771
4SI

0.6 [0.4,0.9)
0.7 [0.3, l.l]

0.9(0 6,1.3]
l.l(0.7,l.7]

l.o1
l.o1

1.0(07, 1.4]
l.l (0.7,1.6]

1.2(09,1.7]
1.3 [0.9, 1.9]

312
233

Hazard Ratio |9S% Cl| by BMI Quintile*

Women surviving
!7 to 29 years
All

Stable Weight

0.003
0.03

Men surviving
17 to 29 years
All

Stable Weight

0.0003
0.01

Hazard Ratio was determined from a proportional hazard regression with indicator variables for BMI quiotiles and a continuous covariate for age.

t

Linear trend was determined from proportional hazard regression with a variable for log(BMI in kg/m1) and a continuous covariate for age. The significance level of the
regression coefficient for log(BMI) is reported as linear trend. A

indicates non-significant trend statistic or that linear trend was not evaluated since significant non-linear

trend was identified.

X

Non-linear trend was determined from proportional hazard regression of an unrestricted quadratic spline model(33). The significance level from a log likelihood ratio test of the
quadratic terms of this model js reported as non-linear trend. A

1

Referent Category

indicates a non-significant trend statistic.

Table 4.
Among older (55-to-84-year-old) never-smoking adults, age-adjusted hazard ratios 195% Cl j relating baseline body mass index (BMI) to
disease-specific mortality risk are presented by gender and study period.
Older Women Who Never Smoked
Older Men Who Never Smoked
Hazard Ratio |9S% Cl| for BMI Quintiles 0
Hazard Ratio |9S% Cl| for BMI Quintiles 0
Deaths
ll-IV
V
Deaths
Cardiovascular
Years 1-12
1.3(1.1.1.61
1.0*
1.311.3, 1.8]
831
0.9(0.7, 1.2]
1.0'
1.4(1.0,18]
333
Yean 7-12
1.3(1.0,16]
1.0'
1.3 (1.2, 1.8)
343
0.9(0.7.1.31
10’
1.411.0,2.1]
187
Coronary
Heart Disease
Years 1-12
1.2(0.9,16]
l.0»
1.7(1.3.2.21
363
0.7(0.4,10]
1.0'
1.2(0.8,1.81
139
Years 7-12
1.2(08,1.7]
1.0'
l.3(l.l,2.l]
224
08(0.3,1.4]
1.0'
1.6(1.0.28)
86
Cerebrovascular
Disease
Years 1-12
l.3(l.0,2.l)
10'
1.1(08, 1.6]
186
1.2 (0.7,2.1]
1.0'
ft (0.5,25)
60
Years 7-12 .
1.5 (0.9,2.4]
1.0'
1.0(0.6,1.71
94
10(0.4,2.3]
1.0*
0.8(0.2,26]
29
Hypertensive +
Other Disease
Years 1-12
1.3(1.0,18]
1.0'
1.6(12,2.1]
302
1.1(0.7,17]
1.0'
1.7(1.1,28]
114
Years 7-12
1.3(0.9,1.81
1.0'
1.7(1.2,23]
227
1.0(06,1.8)
1.0'
1.4(0.8,26]
72
Cancer
Years 1-12
1.0(07,1.4)
1.0'
1.2(0.9,16]
268
0.9(0.6.15]
1.0'
1.4(09,2.3)
103
Years 7-12
0.8(0.5,l.3]
1.0'
1.4(09,2.0)
150
0.9(04,1.7)
1.0*
1.8(10.3.4)
57
Respiratory
Yean 1-12
2.6 (1.5,4.3]
1.0'
1.2(07,2.2]
77
2.2 (1.2,3.8]
1.0*
1.3(0.6,3 0]
57
Years 7-12
3.011.6,5.4]
1.0'
1.7(09,3.4]
55
26(1.4,5.0]
1.0'
1.5(0.6,38]
45
All Other Causes

1

Os

Yean 1-12
Yean 7-12

1.3 (1.0,1.7]
1.3(09,1.8)

ML

1.0'
1.0'

V

1.2(0.9,16)
1.3(09,1.8]

L

290
221

1.0(06,1.5]
1.1(06,1.7)

1.0'
1.0'

l.l(0.7.l.8]
1.3(0.7,22)

138
93

llazanl Ratio was dclcnniocd from a Cox Proportional hazard model with indicator variables for BMI quintiles and a continuous covariate Tor age.

1

Referent Category

0

Quintile cutpoints for baseline BMI among older women are as follows: quintile I - 13.3-20.6 kg/m1, quintiles ll-IV - 20.7-27.4 kg/m1, quintile V- 27.5-65.6 kg/m1;
Quintile cutpoints for baseline BMI among older men are as follows: quintile I - 13.5-22.3 kg/m1, quintiles ll-IV - 22.4-27.3 kg/m1, quintile V- 27.4-51.7 kg/m1;

Table S. Among never-smoking older (55-84 ycar-old)womcn of (he Adventist I Icalth Study cohort, age-adjusted hazard ratios relating categories of DKU
by hormone replacement therapy use\ to risk of all-cause mortality are given for HMI at baseline, DMI at 17 years before baseline, and DMI at 17 years
before baseline among stable weight} women.
Hormone Replacement Therapy User
for greater than 5 years
Hazard Ratio |95% Cl| for DMI Quintiles#
I
ll-IV
V

Hormone Replacement Therapy User
for up to 5 years
Hazard Ratio |95V. Cl| for UMI Quintiles#

Hormone Replacement Therapy Non-user
Hazard Ratio |95% Cl| for DMI Quintiles#

L

ll-IV

l

ll-IV

Y

l.0[0.7, 1.4]

1.0(0.8,13]

1.3(1.0,19]

1.0(0.6,16)

I.01

1.4(0.9,2 0]

1.611.3,2.1]

1.1(0 9,1.4]

1.5 (1.2, 1.9]

1463

BMi 17 yrs
before baseline 0 8(0.4, 1.5]

l.2|0.9, 1.7)

2.8(1.8,4 5]

1.7(0.9.34)

I.01

2.7(1.6,4 5]

l.9(l.3,2.7|

1.5(1.1,21)

2.2 (1.6,2.0]

757

Stable Weight 0.4 (0.1, 1.2]

1.3(0.8,19]

2 7(1.5,5.0]

2.4 (1.1,5.1]

1.0*

2.6(1.3,5 4]

2.211.3,3.5)

1.4 (1.0,2.1]

1.9(1.3,3 0)

442

All-Cause
Baseline BMi

Deaths

Hazard Ratio was determined from a proportional hazard regression with indicator variables for categories of BMI by homrone replacement therapy use and a continuous
covariate for age.
-J

t

‘Non-user’ indicates cither never used or for mcr user for less than a year; ‘User* indicates current user or former user for a year or more.

t

‘Stable Weight’ indicates that baseline body weight was within 10% of body weight repotted 17 years before baseline

1

Referent Category

#

Quintile cutpoints for baseline BMI among older women are quintile I 3 13.4-20.6 kg/m1, quintiles ll-IV - 20.7-27.4 kg/m1, quintile V° 27.5-65.6 kg/m1;
for BMI at 17 years before baseline among older women are quintile I ■= 17.1-20.6 kg/m1, quintiles ll-IV - 20.7-27.4 kg/m1, quintile V~ 27.5-41.2 kg/m1;
for BMI at 17 years before baseline among stable weight older women are quintile I “ 17.2-20.6 kg/m1, quintiles ll-IV •* 20.7-27.4 kg/m1, quintile V- 27.5-41.2 kg/m1.

Table 6. Among never-smoking older (55-84 year-old)women of Ihc Adventist Health Study cohort, age-adjusted hazard ratios relating categories of DMl
by hormone replacement therapy usef to risk of cardiovascular disease mortality are given for BMI at baseline, BMI at 17 years before baseline, and BMI at
17 years before baseline among stable weight} women.
Hormone Replacement Therapy User
for greater than 5 years
ll-IV

V

Hormone Replacement Therapy User
for up to 5 years
Hazard Ratio |9S% Cl| tor BMI Quintiles*
ll-IV
L
V

Cardiovascular
Disease
Baseline BMI H (0.9,2.3)

l.l[0.S, 1.6]

1.7(1.0,21]

1.2(07,2.2)

1.0’

1.7 (t.0,2.8)

l.l (1.3,2.4]

1.3 (1.0, I.S]

1.9 (1.4.2.7]

841

BMI 17 yrs
before baseline 1.3 (0.3,3.3]

1.6 (0.9,2.6)

4.2 (2.2,8.3)

2.4 (0.9, 6.4)

1.0’

3.3 (1.3,7.0]

2.0 [l.l, 3.6]

2.1 [1.3,3.4)

3.3 (2.0.3.3)

444

Stable Weight

0.6(0.1,2 6]

1.4 [0.7,2.7)

3.7 [1.3,8.9]

2.8(0 9,8.7]

1.0’

3.4 (1.2,9.6]

2.4 [l.l, 4.9]

1.9 (l.l, 3.3]

2.6 [1.4, 4.7]

239

1.4(0 7,2.9]

1.1(06.1.9)

2.0 [1.0,4.2)

1.7(08,3.8]

1.0’

1.4(0 6,3.4]

1.3 [0.9,2.3)

1.3(0 8,2.1]

22(1.3,3.6]

361

BMI 17 yrs
before baseline 1.9 [0.3,7.3]

2.0 [0.8,4.6]

8.1(3.1,21.3]

1.4(0.2,11.2]

1.0’

6.6(2.3,18.8]

2.7 [l.l, 6.8]

2.3 [1.2, 3.4]

4.1 (1.9,9.2]

194

Stable Weight

1.0 [0.1, 8.6]

1.9 [0.6,5.8]

7.3(2.0,27.2]

2.2(0.3,20.1]

1.0*

6.6(1.3,29.4]

3.6(1.1,12.1)

2.5(0.9.69]

3.9(1.4,11.4)

110

Cerebrovascular,
Hypertensive, Other
Cardiovascular
Baseline BMI 1.4 [0.7,2.6]

l.l [0.7, 1.7]

1.4(0.7,2 6]

0.8 [0.3.2.0]

1.0’

1.9 (0.9,3.7]

1.9 (1.3,3.0]

1.3(0.9,2 0]

1.7 (l.l, 2.7]

480

BMI 17 yrs
before baseline 1.0 [0.3,3.5]

1.310.7,2.6)

2.1 [08,6.1)

2.9(1.0,90]

1.0’

1.5 [0.4,5.3]

1.7(0 8,3.6]

19(1.1,3.4]

28(1.5,5.2]

250

Stable Weight 0.4(0.03,3.4)

1.2 [0.5,2.7]

2.0 [0.5,7.5)

3.1(0.8,11.6]

1.0’

2.0 [0.4,9.3)

1.8 [0.7,4 5]

1.6 [0.8, 3.2]

2.0 (0.9,4.2]

149

Hazard Ratio |95% Cl| for DMl Quintiles*

I
All

00

Hormone Replacement Therapy Non-user
Hazard Ratio |9S% Cl| for BMI Quintiles*
ll-IV
Deaths
V
i

Coronary Heart
Disease

Baseline BMI

Table 7. Among never-smoking older (55-$4 year old)women of Ihe Adventist Health Study cohort, age-adjusted hazard ratios relating categories of
baseline DM! by hormone replacement therapy use\ to mortality risk from cancer, respiratory, and other causes.

Cancers (All Sites)

Hormone Replacement Therapy User
Hazard Ratio |95% Cl| for BMI Quintiles M
I
ll-IV
V
0.8[0.4, 1.4)
I.01
1.4 (0.9,2.2)

Hormone Replacement Therapy Non-user
Hazard Ratio |95% Cl) for BMI Quintiles tt
ll-IV
V
1.0 (0.6,1.5]
0.9 [0.6, 1.2]
0.9 [0.6, 1.4]

Deaths
262

1.0 [0.6, 1.9]

89

l

Hormone-RelatedCancer
(Breast, Uterus, Ovary)

1.2 [0.5,2.6]

1.0'

1.0 [0.5,2.1]

0.5 {0.2, 1.2)

Respiratory Disease

1.2(03,4.5]

1.0'

t

4.8(2.2,10.4]

16(0.7,3.3]

2.3 [1.0,5.3]

77

All Other Causes U

0.6 [0.3. 1.2)

1.0'

1.0 (0.6, 1.8]

1.8 [1.2,2.7]

1.1(0 8.1.5]

1.4 [l.0,2.l]

283

0.5 [0.3,0.9]

Hazard Ratio was determined from a proportional hazard regression with indicator variables for categories of BMI by hormone replacement therapy use and a continuous
covariate Tor age.
<1
VO

t

'Non-user* indicates either never used or former user for less than a year; 'User* indicates current user or former user for a year or more.

t .

No respiratory disease deaths occurred for women of this category

1

Referent Category

8

Quintile cutpoinls for baseline BMI among older women are as follows: quintile I - 13.4-20.6 kg/m1, quintiles ll-IV - 20.7-27.4 kg/m*. quintile V- 27.5-65.6 kg/m1;

II

Causes unrelated to cancer, respiratory diseas, or cardiovascular disease.

Figure 1. Among never-smoking older women (ages 55-84 years at baseline), age-adjusted hazard
ratios for nine categories of body mass index (BMI, kg/m2) by hormone replacement therapy use
are given that relate BMI at baseline to 12-year all-cause mortality risk, BMI at 17 years before
baseline to 17-29 year all-cause mortality risk, and BMI at 17 years before baseline to 17-29 year all
cause mortality risk among the stable weight (baseline body weight was within 10% of body weight
17 years before baseline)*.

* Hazard ratios are computed relative to women of DMI 20.7 to 27.4 kg/m2 who were users for up to 5 years; Hazard ratio and 95%
confidence interval values for each of the categories are given in Table 5.

oo

o

Body Mass Index at Baseline (1463 deaths)

3
• 2

!
Non-User

X

1 Hazard
Ratio

User, up to 5 yearsV

■ 0.5

User, greater than 5 years'
13.4-20.6

20.7-27.4

27.5-65.6

0.3

Body Mass Index

Body Mass Index at 17 years before Baseline (757 deaths)

3
■ 2
Non-User

1 Hazard

\

Ratio

User, up to 5 yearsV
User, greater than 5 years'
17.1-20.6

20.7-27.4

27.5-41.2

■ 0.5
0.3

Body Mass Index

Body Mass Index at 17 years before Baseline among
Stable Weight Women (442 deaths)

3
‘ 2

1 Hazard

Non-User
User, up to 5 yearsS.

Ratio

1

User, greater than 5 years'
17.2-20.6

20.7-27.4

27.5-41.2

Body Mass Index

81

• 0.5
0.3
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Appendix
Table Al.
Selected baseline characteristics of the older (55-84 year old) never-smoking
women of the Adventist Health Study are given for categories of body mass index (BMI) by
hormone replacement therapy (HRT)*.

Physician Visit
within the past two
years(%)
HRT Non-user
HRT User up to 5 years
HRT User for > 5 years
> 12 years of Education (*/•)
HRT Non-user
HRT User up to 5 years
HRT User for > 5 years
High Physical Activity Level (%)t
HRT Non-user
HRT User up to 5 years
HRT User for > 5 years
Mean Saturated Fat Intake (g/day)
HRT Non-user
HRT User up to 5 years
HRT User for > 5 years
Alcohol Use(a/«)$
HRT Non-user
HRT User up to 5 years
HRT User for > 5 years
Vegetarian(%)§ •
HRT Non-user
HRT User up to 5 years
HRT User for > 5 years
Diabetes (*/•)
HRT Non-user
HRT User up to 5 years
User for > 5 years
High Blood Pressure (%)
HRT Non-user
HRT User up to 5 years
HRT User for > 5 years

BMI Quintile

BMI Quintile

BMI Quintile

I
13.4-20.6 kg/m:

IMV
20.7-27.4 ke/m1

V
27.S-65.6 ke/tn2

83

92
95

84
92
95

87
96
95

51
61
62

48
65
64

41

42

41
40
43

35
35
31

21
21

21
22
22

22
23
22

2

3

2
2

5
5

4
3
3

57
58
55

43
34
47

6
4
4

12
16
10

31
26
32

49
54
50

37
44
20

71

76
68
5
4
6

24

16
22

56
58

*
‘HRT Non-user’ indicates either never used or former user for less than a year, ‘HRT User up to 5 years’ indicates
current user for up to 5 years or former user for 1-5 years; ‘HRT User for greater than 5 years’
current or former user for
greater than 5 years.
t
Frequent (15 minutes or more per session, 3 times or more per week) participation in vigorous leisure-time
or occupational physical activity.
i
*
Ever used Beer, Wine, or Liquor
Meat
Intake
less
than
once
per
week
§
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CHAPTER 5
STUDY III: AGE, WEIGHT GAIN, AND MORTALITY AMONG ADULTS WHO
NEVER SMOKED

Preface to the Manuscript

The accumulated findings from the Adventist Mortality Study (previous reports,
Study I) and the Adventist Health Study (Study II) indicate an increase in risk of all-cause
and disease specific mortality for a body mass index of > 27 kg/m2 among never-smoking
adults. It is noteworthy, however, that the risk due to high body mass index does seem to
attenuate with age. This effect has been reported in other populations and a number of
causal and non-causal interpretations of the effect have been made. One possibility that
has been raised is that the accuracy of the body mass index as a measure of adiposity may
be lower among older adults due to age-related changes in body composition.
In Study III, I have continued the investigation of adiposity in relation to mortality
among never-smoking California Seventh-day Adventists. What distinguishes this study
from the previous studies of this population is that I have used weight gain rather than the
body mass index as the measure of adiposity. The rationale for this method is that since
weight gain among older adults almost certainly indicates increases in fat mass, weight
gain is less likely to be confounded by body composition than the body mass index.
The methodology for Study III is similar to Studies l-ll in using a survival analysis
with time on study as the time variable and stratification by age at baseline. This allows
for a crude estimate of the effect of adiposity on attained age. To further explore how the
risk due to adiposity varies by age, I have also included an analysis in the Appendix
(“Obesity and Weight Gain in relation to Attained Age Among Adults who Never
Smoked”) that relates obesity and weight gain to attained age.
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Abstract
In a 29-year prospective cohort study of 6,030 never-smoking adults (ages 25-82),
we examined the relation between change in body weight from baseline to 17 years after
baseline and the subsequent 17-29 year risk of all-cause mortality. We computed ageadjusted hazard ratios for change in body weight (body weight at year 17 - body weight at
baseline) from a proportional hazard regression model.

Among men, we found that

large weight gains (> 20 kg) were associated with a more than four-fold elevation in risk
(HR for > 20 kg relative to -4 to +4 kg = 4.7 [ 1.7,12.8]), and that this risk did not
attenuate when the analysis was restricted to older men whose weight gains at year 17
were recorded at the sixth, seventh, and eighth decade (HR for > 20 kg relative to -4 to +4
kg = 7.9 [1.9, 32.1]). Among the heaviest men and women (body mass index greater
than 27 kg/m2), we found a more than two-fold increase in risk for moderate weight gains
(10-19 kg) that also did not attenuate when the analysis was restricted to the older adults
whose weight gains were recorded at the sixth, seventh, and eighth decade. We found
that weight loss of > 10 kg was associated with an increase in risk among all adults, but
could not determine the extent to which this relation was attributable to disease-related
weight loss. Our findings from never-smoking 25-82-year-old adults implicate weight
gains of > 10 kg as a risk factor with effects that do not attenuate with age.
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Introduction
Although numerous prospective studies identify obesity among adults at the third
to the seventh decade as a risk factor for fatal disease (1-2), a few recent studies have
shown that after the seventh decade, the risk due to obesity seems to substantially
attenuate with age (3-6). These recent findings are primarily from studies that relate the
body mass index (weight in kilograms divided by height in meters squared) to mortality
risk, and have been used to question whether adiposity remains an important risk factor
after the seventh decade of life (7-8).
When considering this question, two methodologic issues concerning prospective
studies that relate body mass index (BMI) to mortality risk are noteworthy. First, if
obesity is an etiologic risk factor for a disease whose pathogenesis involves large weight
loss, then the true contribution from obesity to the risk of death from this disease may be
obscured if anthropometric data is collected after disease onset. Second, a number of
investigators have proposed that a meaningful comparison of the BMI-Mortality relation
across age stratum can be hindered by the age-related loss of lean body mass that starts at
the fifth decade and progresses rapidly after the seventh decade (9-10). This effect
predicts that older adults may have a greater fat mass than younger adults of the same
calculated BMI. If this bias is differential across levels BMI, then risk estimates for
higher BMI may attenuate with age.
Can such methodologic issues be addressed in prospective investigations that
relate weight-for-height indices to survival? The effect of disease-related weight loss
occurring over long periods (> 15 years) could conceivably be captured in long-term
prospective follow-up where body weight is collected both at baseline and during the
follow-up. The effects of age-related changes in the relative amount of fat mass and fatfree mass are more subtle and are not likely to be detected by a baseline measure of
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weight-for-height. In this context, it is noteworthy that in most cohorts large gains in
body weight occurring from middle-age to older age or during older age, are primarily
attributable to increases in fat mass. Therefore, the use of weight gain rather than
weight-for-height may give greater insight into the true impact of adiposity on survival
after the seventh decade.
The purpose of our investigation was to study the effect of weight gain occurring
throughout adulthood on the risk of death among healthy adults. We have related weight
gains occurring over a 17-year interval to the subsequent 17-29 year risk of mortality
among 6,030 never-smoking adult (ages 25-82 years) cohort members of the Adventist
Mortality Study (1960-1985) and Adventist Health Study (1976-1988) who never smoked
cigarettes and who had no history of coronary heart disease, stroke or cancer. To
determine whether the weight gain-mortality relation changes with age, we have
conducted separate analyses of middle-aged (age 25-44 years) and older (age 45-82 years)
women and men. Since our records on the weight loss that occurred among cohort
members over the 17 year interval do not allow us to distinguish between intentional
weight loss and disease-related weight loss, we have reported the risk due to weight loss,
but have forgone a causal interpretation of the effect.
Methods
Study Population
A population of California Seventh-day Adventists was identified by a census
taken from households listed on the church membership rosters in 1958 (n= 57,707, aged
25 years or older) and in 1974 (n=59,081, aged 25 years or older). The details of each
census have been previously described (11-13). The population identified in the 1958
census was used to enroll a prospective cohort study in 1960 (Adventist Mortality Study)
and the population identified in the 1974 census was used to enroll a prospective cohort
study in 1976 (Adventist Health Study).
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In 1960, 27,530 non-Hispanic white cohort members of the Adventist Mortality
Study (AMS) completed the American Cancer Society Questionnaire and were enrolled
in 26 years of mortality surveillance. In 1976, 34,198 non-Hispanic white cohort
members of the Adventist Health Study (AHS) completed a lifestyle questionnaire
(75.1% response rate) and were enrolled in 12 years of mortality surveillance. Using the
records from the AMS and AHS cohorts, we have identified the 8,386 adults who were
members of both cohorts. These adults became the study population for the present
cohort study. These adults underwent 29 years of mortality surveillance (1960-1988),
with data obtained at baseline and 17 years after baseline.
During 17-29 years of follow-up, deaths in the study population described above
were ascertained by record linkage with the California Death Certificate File, record
linkage with the National Death Index, and use of church records to obtain sufficient
information on a potential decedent that would enable the AHS to order a death
certificate. The validity of the record linkage procedure has been evaluated and it was
found that 3-4% of the deaths in the study population were not ascertained by the record
linkage procedure.
In the study population described above, there was not a sufficient number of
current smokers, former smokers, or subjects with history of coronary heart disease,
stroke, or cancer to allow for separate analyses of each group. To account for possible
differences in the predictors of mortality for these groups, we restricted the analysis to the
6,030 never-smoking cohort members with no history of coronary heart disease, stroke,
or cancer after 17 years of follow-up.
Questionnaires administered in 1960 and 1976
In 1960, subjects completed the four page American Cancer Society questionnaire
that has been previously described. In 1976, subjects completed a previously described
lifestyle questionnaire for the AHS that included items on demographics, dietary intake,
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anthropometric data, physical activity level, psychosocial factors, medication use, and
diagnosed disease history.
Height in inches (without shoes) and weight in pounds (in indoor clothing) were
obtained from both questionnaires. The validity of the anthropometric data was tested in a
random sample of 118 AHS cohort members (14) in which the correlation between body
weight given on the 1976 AHS questionnaire and body weight measured by a dietitian
(up to one year after baseline) was 0.94 for women and 0.96 for men. The correlation
between body height given on the baseline questionnaire and body height measured by a
dietitian (up to one year after baseline) was 0.94 for women and 0.96 for men.
Dietary intake was determined from the 1976 questionnaire that included 55
semiquantitative food frequency items. A total meat index was determined from items
on the current frequency of consumption of all meats and specific meats. Data from a
validity substudy (15,16) of 147 AHS cohort members indicated that the corrected
correlation (17) between this questionnaire index and the corresponding measures from
five 24-hour recalls was 0.83. A physical activity index was calculated from the response
to vigorous leisure-time or occupational activities items on the 1976 AHS questionnaire
and classifies subjects into a “high” category for frequent (15 minutes or more per
session, 3 times or more per week) participation in vigorous activity, a “moderate”
category for less frequent (< 15 minutes per session, < 3 times per week) participation in
vigorous activity, and a “none/low” category for a “rarely or never” response to vigorous
activity items. Similar vigorous items activity are positively correlated with maximal
treadmill time among non-Hispanic white Adventists (18).
Among women, data on reproductive variables were taken from the 1976 AHS
questionnaire. Menopausal status was determined from the response to items on the
regularity of menses, cessation of menses, and reasons for cessation of menses (natural,
surgical). Items on the use (current, past, never) and duration of use (<1 to > 10 years)
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of ‘hormone medicines for menopause (premarin or others)’ were used to classify
women as non-users (never used or former user for less than a year) or users (current use,
former user for a year or more).
Other variables used in the analysis were also taken from the 1976 AHS
questionnaire and include alcohol use (beer, wine, or liquor), years of education, marital
status (currently married, other), and disease history (coronary heart disease, cancer,
stroke, hypertension, diabetes).
Statistical Analysis
The major study endpoint was all-cause mortality (ICD-9: 0-999). Change in
body weight in kilograms was determined from the difference between body weight given
17 years after baseline and body weight at baseline and was categorized into weight gain
(> 20 kg, 10 to 19 kg, 5 to 9 kg), stable weight (-4 kg to 4 kg), and weight loss (-5 to -9
kg, < -10 kg). Baseline body mass index (BMI) was determined using height and weight
at baseline. BMI was categorized into quintile-based categories for the analysis of
women (I, < 20.6 kg/m2; II-IV, 20.6-27.4 kg/m2; V, > 27.4 kg/m2) and men (I, < 22.3
kg/m2; II-IV, 22.3-27.3 kg/m2; V, > 27.3 kg/m2).
Hazard ratios for change in body weight were computed relative to the stable
weight category (-4 kg to 4 kg) from a proportional hazard regression with time on study
(in months) as the time variable. All models included a continuous variable for age at
baseline, and in larger models additional covariates were tested.
The model assumption was evaluated by adding product terms for change in body
weight x time on study and by examining age-adjusted (by direct standardization)19 loglog plots of the product limit estimator of the survival function for categories of change in
body weight. We also evaluated possible dependency on follow-up time by dividing the
17-29 year follow-up period into two smaller study periods (years 17-23, years 23-29) of
approximately equal person-years and determining the relation between change in body
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weight and mortality for each study period.
Results
During 17-29 years of follow-up, we identified 1,352 deaths in the analytic
population. In Table 1, selected characteristics of the population, reported either at
baseline or 17 years after baseline, are given by gender and category of change in body
weight. Subjects who experienced weight gains of > 10 kg after 17 years of follow-up
tended to have higher meat intakes, lower participation in vigorous activities, a high
blood pressure (physician diagnosed), and higher baseline BMI. Subjects who
experienced weight losses of > 10 kg after 17 years of follow-up tended to also have a
higher baseline BMI and a lower participation in vigorous activities, but were distinct
from other weight variability categories in having a higher prevalence of diabetes.
Weight Variability and Mortality
In table 2, we examined the age-adjusted relation between body weight variability
and 17-29 year mortality risk and found an inverse relation among women and a J-shaped
relation among men. In table 3, we conducted this analysis for two age strata (middleaged, 25-44 years at baseline; older, 45-82 years at baseline) and found that among
women the decreased risk associated with weight gains was primarily among the older
women, and among men similar non-linear relations indicating risk for weight gain and
weight loss remained among both middle-aged and older men.
Weight Variability. Body Mass Index, and Mortality
In table 4, we examined the age-adjusted relation between categories of body
weight variability by BMI and 17-29 year mortality risk. Among women, we found an
increased risk due to weight gains of 5-19 kg only among those in the highest BMI
quintile, and an increased risk due to weight loss of 5-19 kg that was evident across the
full range of BMI, but most prominent in the highest BMI quintile. Among men, we
found an increased risk due to weight gain among those in the highest BMI quintile and
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an increased risk due to weight loss of 10-19 kg across the full range of BMI. The
direction of these associations was not substantially altered by restriction of the analysis
to older subjects (45-82 years). It is noteworthy, however, that the increases in risk due
to weight gains of 10-19 kg among the adults in the highest BMI quintile were more
pronounced among the older subjects.
Weight Variability. Body Mass Index. Menopausal Status.
and Mortality among Women
In table 5, we conducted further analysis to assess whether the age-adjusted
hazard ratios for categories of body weight variability by BMI varied by baseline
menopausal status. We found that 1) among women in the middle BMI quintiles weight
gains of 10-19 kg were protective among post-menopausal women, but not among pre
menopausal women 2) among women in the high BMI quintile weight gains of 10-19 kg
were associated with a more than four-fold increase in among post-menopausal women,
but that the hazard ratio for the same category among pre-menopausal women was close
to unity 3) weight loss was stronger risk factor among pre-menopausal than among post
menopausal women.
Multivariate Models
The age-adjusted analysis described in Tables 2-5 was also conducted after
inclusion of other covariates (education, physical activity, alcohol use, meat intake) into
the models. We found that this multivariate adjustment had little effect on the hazard
ratios for weight variability or weight variability by BMI.
Discussion
We have examined the relation between change in body weight over a 17 year
interval and the subsequent 17-29 year risk of all-cause mortality among 6,030 neversmoking, non-Hispanic white adults (ages 25-82 years). Our discussion of the findings
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focuses only on the weight gain-mortality relation since, as mentioned above, we cannot
determine the extent to which the weight loss-mortality relation in the population we
studied is attributable to disease-related weight loss.
The findings on weight gain in relation to mortality among men indicate that large
weight gains (> 20 kg) were associated with a more than four-fold increase in risk (HR
relative to -4 to +4 kg = 4.7 [ 1.7,12.8]), and that this risk persisted among older men
(ages 45-82 years) whose weight gains were recorded at the sixth, seventh, and eighth
decade (HR relative to -4 to +4 kg = 7.9 [1.9, 32.1]). We found further support for the
importance of weight gain as a risk factor among older men in our findings indicating
that moderate weight gain (10-19 kg) among the heaviest older men (BMI > 27.4 kg/m2)
was associated with a more than two-fold elevation in risk (table 4). These data therefore
suggest that weight gain can be a potent risk factor among men up to the eighth decade of
life, and that the importance of this risk does not appear to diminish with age.
The findings among women are in contrast to the findings among men in their
implication that large weight gains (> 20 kg) may be associated with a decrease in risk
among older women (table 3). There is, however, a similarity to the findings among men
in the data for the heaviest women (BMI > 27.5 kg/m2) indicating that moderate weight
gains (10-19 kg) were associated with a more than two-fold elevation in risk, and that this
risk remained evident among the older women (table 4). The data for women therefore
suggest that weight gain may be a risk factor among the obese, and add the possibility
that the risk does not appear to attenuate with age.
Our findings raise the possibility that the risk due to large weight gain among the
adults we studied may have been dependent on gender and age (table 2-3 ). One possible
causal interpretation of the apparent protective effect of large weight gain among older
women (table 3) is a hormonal pathway whereby an increase in fat mass among older
post-menopausal women results in an increase in adipose tissue-derived estrogen levels
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(20). Since the adipose tissue becomes a primary source of endogenous estrogens after
menopause, an increase in adipose tissue would therefore only be causal as a protective
factor among the older post-menopausal women. The data in table 5 provides support for
this hypothesis in its implication of a protective effect for weight gain among post
menopausal women in the middle BMI quintiles, but not among pre-menopausal women
in the middle BMI quintiles.
Another possible interpretation of the gender difference in the risk due to large
weight gain might involve the difference in body fat distribution between men and
women (10). Specifically, the greater tendency toward abdominal deposition of body fat
among men taken together with the especially potent risk due to increased body fat in this
area, raise the possibility that the especially potent risk due to large weight gains among
men may be due to the higher prevalence of abdominal obesity that results from the gains
among men.
It is important to note that our data on change in body weight are obtained from a
report of body weight at baseline and 17 years after baseline. Therefore, a possible
limitation of our study is that the subjects in the “stable weight” referent may have cycled
through a number of gains and losses during the 17-year interval. If this cycling is itself a
risk factor, then the effect of such a bias would likely be to attenuate the risk for weight
gain relative to stable weight and weight loss relative to stable weight. This effect
therefore provides a non-causal interpretation for the apparent protective effect of
moderate weight gains among older women.
Among never-smoking adults we identified a increased risk due to weight gains
among men and obese women that remained evident in an analysis that was restricted to
older adults whose gains were recorded at the sixth, seventh, and eighth decade of life.
These findings indicate that adiposity may remain a risk factor among older adults.
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Table 1. Among 6,030 never-smoking adulls of the study population, selected characteristics are given by gender and weight variability (baseline to 17 years
after baseline) category.
Gain
£ 20 kg

Gain
10-19 kg

Gain
S-9 kg

Stable
Weight

Loss
5-9 kg

Loss
10-19 kg

Loss
£20 kg

Frequency(%)

2

7

15

58

12

6

I

Body Mass Index > 25 kg/m1 (%)

56

44

29

29

49

63

90

Alcohol Use(%)

5

4

4

3

I

1

0

Education > 12 y (%)

71

65

64

61

50

42

40

High Physical Activily(%)

27

31

34

39

39

26

20

Diabetes(%)

14

6

4

4

10

14

24

iligh Blood Pressure(%)

51

35

29

27

34

43

36

Meat Intake £ I x / week (%)

57

49

42

31

23

26

34

Hormone ReplacementTherapy(%) 53

58

57

51

32

29

23

Frequency(%)

5

10

65

14

5

1

Body Mass Index > 25 kg/m1 (%) 67

48

37

49

61

75

85

Alcohol Use(%)

6

10

4

4

4

4

0

Education > 12 y (%)

83

75

77

73

70

67

71

High Physical Activity(%)

33

27

36

48

52

46

14

Diabetes (%)

0

4

2

5

5

7

21

High Blood Pressure (%)

44

22

18

17

19

21

21

Meat Intake £ 1 x / week (%)

61

46

42

33

27

31

50

Women

O
to

Men
I

Table 2. Relation between weight variability from baseline to 17 years after baseline and age-adjusted 17-29 year mortality risk among 25-82 year old adults
who never smoked and.at 17 years after baseline, had no history of coronary heart disease, cancer, or stroke.
Hazard Ratio (95% CI| for Body Weight Variability over a 17 year interval*
Gain

Gain
10-19 kg

Gain
S-9 kg

Stable

Weight Loss

Loss

£20 kg

Weight

§-? be

10-i9 kg

Loss
£ 20 kg

Deaths.

Women

0.7 (0.3, 1.9]

i. i (0.7, 1.6]

1.0 (0.7, 1.2]

1.0

1.311.1,1.5]

1.611.3,2.0]

2.812.0,4.0]

950

Men

4.7(1.7,12.8]

0.9(0.5,1.9]

0.9(06,1.5]

1.0

09(0.7,1.2]

1.8(1.3,24]

2.9(1.3.66]

402

O
UJ

♦Hazard ratios were determined from proportional hazard regression with indicator variables for weight variability categories (relative to -4 kg to + 4 kg)
and a continuous covariate for age at baseline.

Table 3. Relation between weight variability from baseline to 17 years after baseline and age-adjusted 17-29 year mortality risk among middle-aged
and older adults who never smoked and, at 17 years after baseline, had no history of coronary heart disease, cancer, or stroke.
Age at First
Report of
Body Weight
at Baseline

Age Range*
at Second
Report of
Body Weight
at year 17

Age Rangef
Attained
during
17-29 years of
follow-up

Hazard Ratio |95% CI| for categories of Body Weight Variability between Baseline and Year 17$
Cain
Gain
Gain
Loss
Loss
Loss
>20 kg
10-19 kg
5-9 kg
Stable
5-9 kg
10-19 kg
>20 kg

Deaths

25-44 years
45-82 years

46-61 years
62-87 years

58-73 years
73-94 years

1.2 [0 4,3.9]
0.3(0.04,1.8]

1.1 [0 6,2.1]
1.0 [0.6, 1.8]

1.2 [0.7, 1.9]
0.9 [0.6, 1.2]

1.0
1.0

2.9 [1.5, 5.5]
1.2 [ 1.0, 1.4]

7.8 [1.1, 56.7]
2.6 [ 1.9, 3.8]
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25-44 years
45-82 years

47-61 years
62-87 years

59-73 years
73-94 years

2.5 [0.6, 10.5]
7.9(1.9,32.1]

0.9 [0.3, 2.4]
0.8 [0.3, 2.2]

1.1 [0.6, 2.3]
0.7 [0.3, 1.3]

1.0
1.0

1.2 [0.5, 2.9]

2.5 [0.8, 8.0]

0.9 [0.7, 1.2]

1.6 [ 1.2, 2.3]

3.4 [ 1.5, 7.7]

69
333

Women
2.5 [0.8, 7.9]
1.5 [ 1.2, 1.8]

Men

*5lh to Ihe 95'1' percentile of age at 17 years of follow-up.
~~ ——
15"’ to the 95"' percentile of age attained during 17-29 years of follow-up.
\ Hazard ratios were determined from proportional hazard regression with indicator variables for weight variability categories (relative to -4 kg to + 4 kg)
and a continuous covariate for age at baseline.
o

Table 4. Weight variability (baseline to 17 years after baseline) and baseline body mass index(DMI) in relation to age-adjusted 17-29 year mortality risk
among adults who never smoked and, at 17 years after baseline, had no history of coronary heart disease, cancer, or stroke.
Hazard Ratio (95% CI| Tor Body Weight Variability by Baseline BMI
(Baseline Body Weight - Body Weight 17 years after Baseline)
Gain
Stable
Loss
Gain
Loss
5-9 kg
Weight
10-19 kg
5-9 kg
10-19 ke

Deaths

All Men
0.5 (0.1,3.31
0.8 (0.3, 2.2]
1.6 (0.5,4.91

l .l (0.4,2.91
0.8 (0.4, 1.5]
1.2 (0.4, 3.2]

0.7 (0.5, 1.0]
1.0*
1.2 (0.9, 1.7]

0.7 (0.4, 1.2]
1.0 (0.7, 1.4]
0.9 (0.5, 1.4]

1.8 (0 6,4.8]
1.9(1.3,29]
1.4 (0.8, 2.4]
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0.9 (0.1, 6.4]
0.3 (0.04, 2.2]
2.4 (0.6, 9.6]

1.0 (0.2, 4.0]
0.4 [0.1, 1.1]
1.4 [0.4, 4.3]

0.6 (0.4, 0.9]
1.0*
1.3 [0 9,2.0]

0.6 [0.3, 1.2]
1.0 (0.7. 1.3]
0.8 [0.5, 1.4]

1.8 10.7,4.9]
1.6 [1.0, 2.5]
1.3 (0.7, 2.2]

324

All Women
BMI Quintile 1
BMI Quintile ll-IV
Quintile V

l.l [04,3.5]
0.9 (0.5, 1.5]
2.6 [1.3, 5.1]

0.8 (0.3.2.1]
0.9 (0.7, 1.3]
2.0(1.2,3.3]

1.2 [0.9, 1.5]
1.0*
1.5(l.2, 1.9]

1.5 [1.0, 2.4]
1.2 [1.0, 1.5)
1.8 [1.4,2.4]

1.2 (0.4, 3.2]
1.7 (1.3, 2.1]
2.1 (i.5,2.9]

909

Older Women
BMI Quintile I
BMI Quintile ll-IV
Quintile V

1.1 [0.3,4.6]
0.8 [0.4, 1.7]
2.9 (1.2,7.0]

0.7 [0.2, 2.7]
0.9 (0.6, 1.4]
1.3 (0.6,2.8]

l.l [0.8, 1.5]
1.0*
1.5 [1.2, 1.9]

1.4 10.9,2.2]
l.l (0.9, 1.4]
1.7 (1.3,2.3]

1.1 [0.4,2.8]
1.5 (1.2,2.0]
2.1 [1.5,28]
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BMI Quintile I
BMI Quintile II-IV
Quintile V
Older Men
BMI Quintile I
BMI Quintile 1I-1V
Quintile V

O

Table 5. Weight variability (baseline to 17 years after baseline) and baseline body mass index(DMI) in relation to age-adjusted 17-29 year mortality risk
among pre-menopausal women and post-menopausal women who never smoked and, at 17 years after baseline, had no history of coronary heart disease,
cancer, or stroke.
Body Weight Variability (Baseline Body Weight - Body Weight 17 years after Baseline)
Gain
Gain
Stable
Weight Loss
Weight Loss
10-19 kg
5-9 kg
Weight
5-9 ke
£ 10 kg
Deaths

O

On

Post-menopausal Women
BMI Quintile 1
BMI Quintile II-1V
Quintile V

1.1 (0.3,4.61
0.2(0.1,0.91
4.7(2.2,10.01

Pre-menopausal Women
BMI Quintile I
BMI Quintile ll-IV
Quintile V

I. I [0.2, 8.0]
1.6 [0.8,3.1]
1.2 [0.3,4.7]

0-7 10.2,2.7J
0.9(0.6,1.31
2.2(1.2,4.11

1.2 [0.3, 4.8]
1.0(0 5,1.7]
1.5(0.5,4.91

1.2 [0.9, 1.51
1.0*
1.5 (1.2, 1.9]

1.3(0.8,2.11
1.2(1.0,1.51
l.7[l.2,2.3]

0.9 [0.4, 2.0]
1.0*
1.9(1.0,3.61

10.2 (3.5,29.71 12.6(1.7,92.81
1.4(0.6,3.31
3.4(1.2,96]
4.0 (1.6, 10,1]
2.8(I.0,7.9J

0.9(0.3,2.71
1.7 [1.3,2.1]
2.2(1.7,3.01
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CHAPTER 6
SUMMARY AND CONCLUSIONS

Summary of the Findings from Studies l-lll

Study I

Among never-smoking adult women of the Adventist Mortality Study, I have
shown that a high body mass index (> 27 kg/m2) was associated with an increased 15-26
year risk of death from all cardiovascular diseases, specific cardiovascular diseases
(coronary heart disease, cerebrovascular disease, hypertensive and other disease), all
cancers, hormone-related cancers, respiratory disease, and all other diseases.
Additionally, I have shown that the increased 15-26 year risk of death due to low body
mass index index (< 21 kg/m2) among apparently healthy older (after the fifth decade)
women was primarily due to cardiovascular and respiratory disease.

Study II

Among never-smoking adults of the Adventist Health Study, I found a direct
positive relation between body mass index and mortality among middle-aged (up to the
fifth decade) men, older (after the fifth decade years) men, and middle-aged women, and
a J-shaped relation among older women. Further study of the older women, revealed that
the risk due to low body mass index was only evident among those older women who had
not undergone post-menopausal estrogen replacement therapy, and that the risk in this
subgroup was primarily due to cardiovascular and respiratory diseases.
109

It is important note that in those population subgroups in which a direct positive
relation was found (middle-aged women, men, older women on hormone replacement
therapy) there was evidence for up to a 60% decrease in risk for the lowest body mass
index category (men, 13.5-22.3 kg/m2; women, 13.3-20.6 kg/m2) relative to the middle
body mass index category (men, 22.4-27.4 kg/m2; women, 20.7-27.5 kg/m2). These data
therefore raise the possibility that risk due adiposity may exist below a body mass index
of 27 kg/m2, a commonly used cut-point for overweight.
The findings from never-smoking adults of the Adventist Health Study given in
Study II are in concordance with findings from never-smoking adults of the Adventist
Mortality Study (1960-1985) and the accumulated evidence from eleven studies of
apparently healthy never-smoking adults (Chapter 2, Tables 2.6-2.7) indicating that low
body weight is associated with increased mortality risk among older women. Findings
from Study II, add the possibility that the risk due to low body weight among older
women was avoided by those who had used estrogen replacement therapy. If confirmed
in other populations, this finding raises the possibility that the risk due to low body
weight observed among the older women may have been due to their lower levels of
adipose tissue-derived estrogens.

Study III

Among never-smoking adults of the Adventist Mortality Study and Adventist
Health Study, I found that a gain in body weight of > 10 kg occurring over a 17-year
interval was associated with an increased 17-29 year risk of all-cause mortality and that
this risk did not attenuate when analyses were restricted to older adults whose weight
gains were recorded at the sixth, seventh, and eighth decade. These data provide
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evidence that risk due to increased fat mass does not attenuate with age.
Conclusions

The findings from a set of three studies of adults who had never smoked cigarettes form
the basis for the following conclusions.

•

An increased mortality risk due to adiposity or weight gain can be experienced
through the eighth decade.

•

An increased mortality risk due to adiposity can be experienced at a body mass index
below 27 kg/m2.

•

Older, post-menopausal women of low body mass (13.4 to 20.6 kg/m2) can
experience an increased mortality risk that may be due to their lower levels of adipose
tissue-derived estrogens.
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APPENDIX
Findings from Men of the Adventist Mortality Study
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Fleur* 1 The relation between body mess index IBMI) and sHeause mortality as shown by ege-adjusted cumulative harard
functions for BMt Quintiles I,I. M-IV and V among never-smoking
middle-aged I30-S4y) men during 26y of follow-up.
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Mictions f0f BMI quintiles I. It-IV and V among never-smoking
older (55-74 y) men during 28 y of lollow-up.
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* Huard ratio was determined from s Cox proportional haiard model with indicator variables for BMI quintile I and V (relative to
euintii* H-IV) and a covariate for age. Deaths and Psrson-Ysars represent only the mortality and survival time occurring within the
Oixen study period (that is. a death at year 9 is assigned 8 y as a non-decedent during 'years 1 to S'. 1 year as a decedent during 'years 9
1° 1*’. and excluded from the analysis for ‘years IS to 26').
trend was determined from s Cox proportional haiard model with a variable for logIBMI in kg/m1) and a covariate for age. The
•gnificanc* level of the regression coefficient (I. where Haiard ratio «(BMI in kg/mV is reported as linear trend when no significant
"Oh-linear trend was identified. -. indicates that this criterion was not met. Linear trend reported in italics print denotes negative linear
trend.
: Non-linear trend was determined from Co* regression of an 'unrestricted quadratic spline moder,1* with variables logIBMI in kg/m'l.
■oglBMI m kg/m1.)1, two quadratic spline terms and a covariat* (or age. The significance level from a log likelihood ratio lest of the
Quadratic terms (log (BMI in kg/m’)1, two quadratic spline terms) is reported as a non-linear trend.

(reproduced with permission from: Lindsted KD, Singh PN. Body Mass and
26-year risk of mortality among men who never smoked: a re-analysis among
men of the Adventist Mortality Study. Int J Obes 1998; 22: 544-548)
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Editorial Comment on Study I

Body Weight and Mortality:
What Is the Shape of the Curve?
As a nation, we are becoming increasingly overweight.
One in three U.S. adults is currently classified as over
weight, compared with fewer than one in four in the early
1960s.1 The mean body mass index of Americans ages
20-74 years has increased from 24.8 kg per m2 during
1960-1962 to 26.3 kg per m: during 1988-1991.1 Being
overweight carries numerous adverse health consequences,2
including premature mortality for both men and women.3,4
In this issue, Singh and Lindsted observe, as have many
others,5 that higher rates of mortality from all causes and
from cardiovascular disease occur among overweight
women.6
Although there is almost universal agreement that being
overweight is associated with poorer health outcomes,
there is no consensus regarding the health risk at the other
end of the weight spectrum, that is, the lower end of the
distribution. There has been considerable debate regarding
whether lower body weights may be associated with higher
mortality rates. Many investigators have described J-shaped
or U-shaped curves when examining the relation between
body weight and mortality rates5; that is, being lean is
associated with increased risk of premature mortality. It has
been proposed that the higher mortality rates at the lean
end of the weight spectrum are artifactual, resulting from
inadequate control for cigarette smoking (since smokers
tend to be lean and also have higher mortality rates) and/or
the inclusion of individuals with subclinical disease (who
are lean owing to weight loss related to their underlying
disease).5 In several recent large-scale prospective studies
that accounted for these biases, no elevation in mortality
rates was observed among the lean.3,4,7
When examining the association between body weight
and mortality, Singh and Lindsted appropriately tried to
minimue these two biases. They circumvented the bias due
to cigarette smoking by including in their analyses only
those women who had never smoked. The unique nature of
the Seventh-day Adventist cohort ensured that a large
proportion of subjects had never smoked. To reduce po
tential bias from antecedent disease, the authors focused on
the subgroup of women who survived 15-26 years after
their initial report of body weight.
Among their main findings, the authors describe differ
ent associations between body mass index and mortality
among middle-aged (30-54 years) and older women
(55-74 years), increased risk of certain fatal cardiovascular
diseases among lean middle-aged women, and an inverse
relation between body mass index and death from respira
tory diseases among both middle-aged and older women.

With regard to effect modification by age, the authors
find stronger associations between body mass index and
mortality- among middle-aged women than among older
women. While this finding may indeed be correct, there
also exist plausible alternate explanations. First, body mass
index may not reflect adiposity as well in older women. For
a given body mass index, an older woman is likely to have
more fat mass but less muscle and lean body mass than a
younger woman. Furthermore, the distribution of body fat
among older women is different from that among those
who are younger.8 With increasing age, fat deposition in
the upper and central body, which is believed to be more
deleterious than lower body obesity,910 increases. In all age
groups, including the elderly, increased waist circumference
and waist-hip ratio are strong predictors of all-cause mor
tality11*13 and cardiovascular disease.11,12,M Therefore, the
imprecision of body mass index as a measure of adiposity
among older women, as well as the different distribution of
body fat at older ages, may attenuate associations with
mortality.
Second, inaccuracies in death certificate diagnoses of
cause of death, particularly among the very old, also may
lead to attenuation of the associations between body mass
index and cause-specific mortality among the older Seventhday Adventist women, who attained ages of 75-96 years at
the end of follow-up. Ascertaining the cause of death
among the very old, in whom advanced atherosclerosis and
other age-related conditions are rampant, can be difficult;
studies have shown important disagreements between the
diagnoses of ischemic heart disease and stroke as docu
mented from death certificates and from autopsy findings.15
Singh and Lindsted also describe increased hazards for
cerebrovascular death and death from hypertensive and
other cardiovascular endpoints associated with low body
mass index among younger women. This finding, how
ever, is based on comparatively few deaths among these
women (26 and 30, respectively). Finally, Singh and
Lindsted observed an inverse association between body
mass index and mortality from respiratory diseases
among both middle-aged and older women, a finding
that the authors view as tentative. Cigarette smoking
should not have caused a bias, since the population
studied was a group of women who reported that they
had never smoked. Although the authors have at
tempted to reduce bias from antecedent disease, there is
no assurance that such bias is completely eliminated.
Bias due to antecedent disease may not disappear even
after 17 years; in a study of men followed for up to 26
years, there was still some indication of bias owing to
preexisting disease 15-19 years after the start of the
study.3 Given the absence of plausible biological expla-
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nations for these findings, the observed associations be
tween leanness and these endpoints are more likely the
result of residual confounding, antecedent disease, or
other artifacts. In the large-scale American Cancer So
ciety cohort,7 no appreciable increase in all-cause or
cardiovascular disease mortality was observed among
lean men or women in any age group through age 84
years.
This study of Seventh-day Adventist women adds to
the already large body of evidence that being overweight
is hazardous and increases the risk of premature mortal
ity from many diseases, including cardiovascular disease,
cancer, and respiratory diseases. The study also raises the
possibility that being lean may increase the risk of mor
tality from respiratory diseases; however, this latter ob
servation could have been artifactual and requires con
firmation in future studies.
I-Min Lee
JoAnn E. Manson
Division of Preventive Medicine.
Department of Medicine.
Brigham and Women's Hospital and
Harvard Medical School,
900 Commonwealth Avenue East.
Boston. MA 02215
(address correspondence to: 1-Min Lee)
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Reliability Analyses on Methods of Nosology
During 1976-1985 a population of 5553 men and 3385 women were
simultaneously followed by the Adventist Mortality Study (1960-1985) and Adventist
Health Study (1976-1988). Deaths in this population were classified by cause using two
different nosologists - the state nosologist for Adventist Mortality Study and a study
nosologist for the Adventist Health Study. An analysis of rate of mismatches between
these nosologists is given below.
Table 1.

Deaths and Mismatches Among Adults undergoing mortality surveillance

by the Adventist Mortality Study and Adventist Health Study.

Total Deaths
Total Mismatches
Mismatches +
correctly classified as
Infectious disease
Endocrine/Nutritional
Mental Disorders
Nervous System
Circulatory
IHD
Stroke
Other
Respiratory
Digestive
Musculoskeletal
Genitourinary
Poisonings/Accidents
Total

Rate of Mismatches

Men

Women

525

745

118

180

14
0

22
3

1
1

0

1

3

106
(50)
(11)
(45)
5

1

2

70
(37)

(12)
(21)
0

1

1
3

0
2

94

142

118-94/525

180-142/745

= 0.046

= 0.051
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Obesity and Weight Gain in Relation to Attained Age among Adults Who Never Smoked

In Study 111,1 found that weight gains of 10 or more kilograms among men and
women of high body mass index (above 27 kg/m2) remained a strong risk factor for all
cause mortality even after restriction of the analyses to older adults (45-82 years at
baseline) whose gains were experienced at the sixth, seventh, and eighth decade (Table 3
of Study III). This finding raises the possibility that the risk due to adiposity does not
attenuate with age.
In this section of the Appendix, I have further explored this possibility by
conducting a survival analysis that uses attained age as the time variable. In the
population described in Study III, I evaluated the relation between attained age and the
following three categories: 1) High BMI + Stable Weight, 2) High BMI + Weight Gain,
and 3) a referent category of Medium BMI + Stable Weight. High BMI is defined as >
27.3 kg/m2 for men and > 27.4 kg/m2 for women; Medium BMI is defined as 22.3-27.3
kg/m2 for men and 20.6-27.4 kg/m2 for women. For men and women, “stable weight” is
defined by weight at year 17 being within 4 kg of weight at baseline, and “weight gain” is
defined by weight at year 17 being 10 or more kilograms greater than baseline weight.
I have used two approaches to relating these three categories to attained age.
First, I have fit proportional hazard models with attained age as the time variable and
included interactions terms with the time variable in order to detect whether the risk
associated with these categories changes with age. Second, I have plotted the loge
cumulative hazards (log (-logS (t)) for these categories against attained age and further
stratified the analysis on baseline age. The remainder of this section includes a summary
of the findings from these methodologies and a conclusion based on these findings.
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Obesity and Weight Gain in relation to Attained Age: Findings from A Modeling
Approach

In tables 2-3 I have presented the findings from proportional hazard models
that include terms for the three categories described above (relative to Medium BMI +
Stable Weight). Among men, interaction terms for these categories did not attain
significance, suggesting that the hazards for these categories do not vary by attained age.
Therefore, parameters from Model 2 in Table 2 can be used to state that among men there
is a 27% increase in risk for high BMI + stable weight (e0 236544) and a marginally
significant (p=0.053) 140% increase in risk for high BMI + weight gain (e0-890675) that
remain relatively constant through the limit of attained age.
Among women, interaction terms for these categories did attain significance,
suggesting that hazards for these categories do vary with attained age. I further explored
this dependency by using the terms from Model 1 in Table 3 to compute hazard ratios at a
range of attained ages. These indicated that the risk due to high BMI + stable weight or
high BMI + weight gain declined from an approximately two-fold increase in risk at 6070 years of attained age to an approximately 50% increase in risk from 80-90 years of
attained age. It is noteworthy that restriction of the analysis to women who were 65-82
years at baseline produced a similar magnitude of attenuation of the risk for high BMI +
stable weight.

Obesity and Weight Gain in relation to Attained Age: Findings from an Approach based
on Hazard Plots

In Figures 1-21 present for each of the three categories described above the plots
of loge cumulative hazard (log (-log (S (t)) versus attained age from an analysis where
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age attained before entry into the study has been censored (left truncation). Among men,
these plots indicate that high BMI + stable weight remains a risk factor through the
beginning of the ninth decade and high BMI + weight gain remains a risk factor through
the beginning of the eighth decade. It is important to note that these are not true “age
limits” but simply represent that the ages after there was not sufficient numbers in the
study population to compute a hazard.
Among women, Figure 2 indicates that high BMI + stable weight remains a risk
factor through the middle of the ninth decade and high BMI + weight gain remains a risk
factor through the beginning of eighth decade. It is noteworthy that the risk due high
BMI + stable weight seems to decrease after the middle of the eighth decade in the
analysis of All Women (ages 25-82 years at baseline), but seems to increase in the
analysis restricted to 65-82 year old women. One possible reason for this difference
is that the analysis of 25-82 year old women may be confounded by age at baseline,
whereas the analysis of 65-82 year-old women may be less confounded due to the use of
a narrower age stratum. Also noteworthy is that the point of cross-over depicted in the
analysis of 65-82 year-old women represents a non-linear variation in the hazards and
therefore would not be modeled by the linear interaction term used in the previous
section.
Conclusion

Obesity and weight gain remain important risk factors through the eighth decade.
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Table 2.
Models to evaluate time dependency for two categories of 25-82 year-old
never-smoking men of high BMI (> 27.3 kg/m2): those who were stable weight (weight at
year 17 within 5 kg of baseline weight) and those who gained weight (> 10 kg). The
referent category is stable weight men of medium BMI (22.3-27.3 kg/m2).
(3*

Standard Error P

0.395765
0.826013
-0.025930
-0.046354

0.21020
0.51511
0.01998
0.06645

0.236544
0.890675

0.17745
0.46056

Model 1 : -2 log Likelihood =1874.775

High
High
(High
(High

BMI and Stable Weight
BMI and Weight Gain
BMI and Stable Weight) x (attained age)f
BMI and Weight Gain) x (attained age)t

Model 2 : -2 log Likelihood =1876.797

High
High

BMIand Stable Weight
BMIand Weight Gain

X2 (df=2) = Model 2

Model 1 = 1876.797

1874.775 =

2.02, p = 0.36

*lrom a Cox proportional hazard regression with attained age as time variable,left
truncation of the time variable, and centralized terms,
t attained age in years and months

Table 3.
Models to evaluate time dependency for two categories of 25-82 year-old
never-smoking women of high BMI (> 27.4 kg/m2): those who were stable weight
(weight at year 17 within 5 kg of baseline weight) and those who gained weight (> 10
kg). The referent category is stable weight women of medium BMI (20.6-27.4 kg/m2).

Model 1 : -2 log Likelihood = 4734.352

High
High
(High
(High

BMI and Stable Weight
BMI and Weight Gain
BMI and Stable Weight) x (attained age)f
BMI and Weight Gain) x (attained age)f

P*

Standard Error P

1.121093
0.667315
-0.067679
-0.049926

0.16878
0.35484
0.01303
0.03311

0.405695
0.481320

0.11767
0.34277

Model 2 : -2 log Likelihood = 4761 .205

High
High

BMI and Stable Weight
BMI and Weight Gain

X2 (df=2) = Model 2

Model 1 = 4761.205

4734.352 = 26.85, p < 0.00001

* trom a Cox proportional hazard regression with attained age as time variable,left
truncation of the time variable, and centralized terms,
f attained age in years and months
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Figure 1.
Plots of the logc of the cumulative hazard function versus attained age
(during 17-29 years of follow-up) for selected categories of BMI and weight gain among
never-smoking men.
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Figure 2.
Plots of the log e of the cumulative hazard function versus attained age
(during 17-29 years of follow-up) for selected categories of BMI and weight gain among
among never-smoking women.
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I am a doctoral student at Loxna Linda University and the first author of the above
referenced manuscript that waa recently accepted at AJE. I need to reproduce this
manuscript in my dissertation, and would greatly appreciate a document providing
official copyright permission from the journal.
Please mail this permission to me at the address given above. Also, 1 would greatly
appreciate a FAX of the permission (to the fax given above) as soon as it is available.
I am attempting to meet a graduation deadline for my dissertation. Any help you can give
me in arranging this permission would be greatly appreciated.
Thank You.
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RE: Article in International Journal of Obesity (Volume 22: pages 544-548)

' 1 am a doctoral student at Loma Linda University (USA) and a co-author of the above
referenced arhclfi^IaU-ObesJ^Sj22:544-548, ••Body_M35Sjn^Mortality....). I need
to rcprodv^-tablcs and figurg&fejrn this article Ur^ydi^crtaiioji^fnd would greatly
appreciate adBS^renFproviding official copyrigETpcrmTssion from Stockton.
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Please mail this permission to me at the address given above. Also, I would greatly
appreciate a FAX of the permission (to the FAX number given above) as soon as it is
available.
Jam attempting to meet a graduation deadline for my dissertation. Any help you can give
me in arranging this permission would be greatly appreciated.
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